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 The final stage in the production of infectious retroviral particles is the scission of 
membrane tethers connecting nascent virions to the host cell. Efficient retrovirus release 
requires late domains, short peptide motifs within the structural Gag proteins that engage 
the cellular Class E vacuolar protein sorting (VPS) machinery. Three classes of late 
domains have been described in retroviruses, each with its own cellular interaction 
partners: PT/SAP domains bind Tsg101, LxxLF or YPXL domains bind ALIX, and PPxY 
domains bind Nedd4-like HECT ligases, a class of ubiquitin ligase enzymes. The 
functional link between HECT ligases and the VPS pathway has not been defined, but 
multiple lines of evidence suggest that ubiquitin is generally important for late domain 
activity. Retroviral Gag proteins are often monoubiquitinated, and depletion of free 
cellular ubiquitin results in accumulation of assembled but immature virions at the cell 
surface, attached to the cell by membranous stalks. Moreover, mutation of multiple 
ubiquitin acceptor sites (lysine residues) in HIV-1 and RSV Gag proteins markedly 
inhibits budding. However, the precise role of ubiquitin in retroviral particle release is 
poorly understood. 
 To test the importance of direct Gag ubiquitination for viral particle release we 
constructed a prototype foamy virus (PFV)-derived Gag protein devoid of lysine residues, 
which can assemble at the plasma membrane in the absence of other viral protein 
expression. Efficient release of lysine-free PFV Gag virus-like particles (VLPs) required 
 
the PSAP late domain and an intact Class E VPS pathway. Remarkably, the MLV PPXY 
late domain could functionally replace the PSAP motif in lysine-free Gag, retaining its 
capacity to engage HECT ubiqutin ligases and support particle release. Moreover, 
overexpression of catalytically active HECT ligases markedly stimulated PPxY-
dependent lysine-free PFV Gag budding, while catalytically inactive mutants did not. 
Interestingly, the ability of different HECT domains to promote PFV VLP release 
correlated with their autoubiquitination activity, but not with their ability to ubiquitinate a 
Gag substrate containing late domain-proximal lysine residues. 
 Importantly, direct fusion of ubiquitin to the C-terminus of lysine free PFV Gag 
rescued budding in the absence of conventional late domains. Additionally, ubiquitin 
fusion dramatically enhanced PSAP-dependent budding. This effect was observable only 
when a large fraction of Gag carried ubiquitin. Ubiquitin-dependent particle production 
was abolished by overexpression of dominant negative Vps4 and disruption of the Ile44 
hydrophobic patch in ubiquitin. Individual depletion of Tsg101 and ALIX partially 
suppressed ubiquitin-dependent budding, and the inhibition was enhanced by 
simultaneous depletion of the two factors. Thus, multiple ubiquitin-binding Class E 
factors may provide redundant mechanisms for engaging the VPS machinery, which is 
essential for ubiquitin-dependent budding. 
 Our findings suggest that deposition of ubiquitin at sites of virion assembly by 
HECT ligases provides docking sites for class E factors, in effect serving as an alternative 
or additional late domain. However, since both lysine free and ubiquitin fused versions of 
PFV Gag proteins support budding, the precise nature of the ubiquitin acceptor, be it the 
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Chapter I. Introduction 
 
 Retroviruses comprise a diverse family of RNA viruses that infect virtually all 
vertebrates. They are notable for their ability to establish persistent infection by making 
DNA copies of their genomes and integrating them into the host’s genomic DNA [1], 
using virally encoded reverse transcriptase [2] and integrase enzymes [3-5]. Though most 
retroviruses are relatively benign, several members are highly pathogenic and have been 
associated with tumorigenesis [6-8] and immune deficiency [9]. An enormous amount of 
research in recent decades has been devoted to the study of human immunodeficiency 
virus (HIV)-1, the causative agent of AIDS, which has killed over 25 million since its 
discovery. However, retroviruses also hold great interest as vectors for delivery of gene 
therapy and markers of evolutionary history. 
 Retroviral particles consist of a membrane-enveloped protein shell that collapses 
upon maturation to form a dense spherical, conical, or cylindrical inner core (reviewed in 
[10,11]). This core, or capsid, carries essential viral enzymes and two single-stranded 
linear copies of the RNA genome, tightly complexed with nucleocapsid proteins. The 
phospholipid bilayer that covers the virion is derived from the host cell membrane and 
contains highly glycosylated envelope proteins, which protrude from the surface and 
determine host cell tropism. 
Retrovirus replication cycle 
 The infectious cycle (illustrated in Fig. 1) begins with the initial attachment of 








Figure 1. The retroviral lifecycle. (A) Typical route of cell infection and integration into 
host genome. (B) Typical route of virion production, including gene expression, 
assembly, and release. Taken from Goff, Nature Reviews Microbiology, 2007 [12]. 
 
[13,14]. This concentration of viral particles at the plasma membrane facilitates the 
recognition and binding of specific host receptors by the surface-binding region of viral 
envelope proteins [15-18]. A series of conformational changes within the transmembrane 
region of envelope proteins mediates the fusion of viral and cellular membranes, allowing 
the release of the capsid into the cytoplasm (reviewed in [19,20]). Fusion may be 
triggered directly by receptor binding at the plasma membrane [21] or by exposure to low 
pH in acidified endosomes following internalization [22-24]. Although some DNA 
synthesis may begin in the virion [25-27], the majority of reverse transcription in most 
retroviruses occurs soon after entry into the host cell and may be triggered by the high 
concentration of deoxyribonucleotides in the cytoplasm [28,29]. Upon entry the viral core 
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begins a process of progressive disassembly, known as uncoating [29-31]. The pre-
integration complexes (PICs), consisting of viral cDNA and associated enzymes, 
structural and accessory proteins, migrate toward the nucleus by engaging the cellular 
actin cytoskeleton and/or microtubule network and associated motor proteins [30,32-34]. 
 In order to access the host cell genome, retroviral PICs must penetrate the nuclear 
membrane. Since lentiviruses can infect non-dividing cells [35-38], their PICs 
presumably enter the nucleus through the nuclear pore. Several lentiviral proteins and the 
viral DNA itself have been reported to possess nuclear targeting elements [39-44]; 
however, none of them have been unequivocally shown to be absolutely required for PIC 
nuclear import [45-48]. Most retroviruses must wait for nuclear envelope breakdown 
during mitosis to access the nucleus and thus depend on the cell cycle for productive 
infection [37,49,50]. The viral integrase enzyme catalyzes the double transesterification 
reaction to insert the viral cDNA into the host genome [51-54]. Although integration site 
selection is generally not sequence-specific, it may be influenced by regional chromatin 
structure [55,56] and interactions between integrase and chromatin-binding proteins [57-
60]. Retroviral integration is essentially permanent and allows the viral genome to persist 
as a provirus for the lifetime of the cell. 
 The cellular transcription machinery treats the provirus as a host gene, generating 
a capped and polyadenylated viral mRNA (reviewed in [61]). Most proviral promoters, 
located within the long terminal repeat (LTR) regions, are constitutively active; however, 
some LTR promoters require transactivation by virally encoded regulatory factors [62]. 
Nuclear export of unspiced or partially spliced viral mRNA requires interaction of 
specific RNA structural elements with the host RNA export machinery, either directly or 
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through the activity of viral cofactors [63-66]. Simple retroviruses encode only the gag, 
pol, and env genes, while complex viruses encode additional regulatory or accessory 
genes. The gag gene codes for the structural proteins that drive particle assembly and 
make up the viral core [67,68], pol codes for essential enzymatic functions [2-4,69], and 
env codes for the envelope glycoproteins that mediate host receptor recognition and 
membrane fusion. The Gag structural precursor is translated by free ribosomes from 
unspliced RNA. In most retroviruses, one in every 10-20 translation events results in 
readthrough [70,71] or frameshifting [72,73] at a slippery sequence before the Gag stop 
codon, generating the Gag-Pol polyprotein. Env proteins are translated from singly 
spliced subgenomic mRNAs on membrane-bound ribosomes in the endoplasmic 
reticulum, where they fold, oligomerize, and become heavily glycosylated. En route to 
the plasma membrane, Env traffics through the Golgi, where it gets cleaved by furin-like 
proteases to generate surface and transmembrane subunits (reviewed in [12]). 
In most retroviruses assembly of extracellular virions is driven primarily by Gag, 
and expression of the Gag protein in the host cell is sufficient for the formation and 
release of virus-like particles (VLPs) (Fig. 2). The M (membrane binding)-domain of Gag 
mediates membrane association through interactions between a patch of hydrophobic and 
basic residues near the amino terminus with membrane phospholipids. Fatty acid 
(myristate) modifications of some retroviral Gag proteins facilitate membrane targeting 
by inserting into the plasma membrane [74-77]. The myristate may be buried in a 
hydrophobic pocket of Gag and exposed upon Gag polymerization [78-81]. The I 
(interaction)-domain within the C-terminal half of Gag mediates Gag-Gag interactions 
that drive particle assembly [82-84]. The L (late budding)-domain, which may be located 
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either within the N-terminal third or at the C-terminus of Gag, is essential for efficient 
membrane separation between the fully assembled virion and the host cell (reviewed in 
[85]). Two major routes of assembly have been observed for different viruses. In some 
viruses Gag is targeted directly to the plasma membrane [86,87], where lateral Gag-Gag 
interactions and bud growth induce outward membrane curvature. Other viruses pre-
assemble in the cytoplasm before trafficking to the plasma membrane for envelopment 




Figure 2. Assembly of HIV-1 particles. Gag proteins associate with cellular membranes, 
and their oligomerization induces membrane curvature. Viral enzymes are typically 
incorporated into virions as part of Gag-Pro-Pol polyproteins, which co-assemble with 
Gag. Other viral components are incorporated through interactions with Gag. After 
particle release, the viral protease cleaves Gag into MA, CA, and NC and releases the 
viral enzymes to generate mature infectious virions. Adapted from Pelchen-Matthews, et. 
al. Trends in Microbiology, 2004 [90]. 
 
Pol typically gets incorporated into virions as a Gag-Pol polyprotein, which 
associates with membranes as it co-assembles with Gag, thereby allowing the virus 
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control over the stoichiometry of structural and enzymatic components in the virion. Env 
is thought to be incorporated through interactions between its cytoplasmic tail and the N-
terminus of Gag [91]. Env may also target Gag to specific membrane domains [92-94]. 
The viral RNA contains packaging signals near the 5’ end, which mediate its 
incorporation into nascent virions by interactions with basic Cis-His sequences in the 
nucleocapsid region of Gag [95,96]. The RNA is packaged as a dimer, held together by 
base-pairing at specific palindromic sequences, known as dimer linkage structures (DLS) 
[97,98]. 
Formation of mature infections particles requires cleavage of the Gag and Gag-
Pol precursors by the viral protease to generate separate matrix (MA), capsid (CA), and 
nucleocapsid (NC) structural proteins, and protease (PR), reverse transcriptase (RT), and 
integrase (IN) enzymes [69]. NC forms a tight complex with the viral RNA inside the CA 
core, while MA remains closely associated with the inner leaflet of the lipid envelope. 
Maturation is closely linked to budding, and protease activation may be induced by its 
oligomerization during Gag and Gag-Pol co-assembly. However, additional triggers must 
occur, since viruses that assemble in the cytoplasm mature only after their release from 
the host cell [99]. 
 The membrane fission event that separates nascent virions from the host cell, and 
from each other, is not spontaneous. Retroviral Gag proteins and structural proteins of 
some other enveloped viruses encode short peptide motifs, called late (L)-domains, which 
are essential for efficient virus particle release [100-102]. Inhibition of late domain 
function causes fully assembled immature virions to remain tethered to the cell surface by 







Figure 3. Late domains promote efficient separation of fully assembled virions from the 
host cell. (A-C) Thin section electron microscopy analysis of (A) MLV with a mutated 
PPPY motif [103], (B) MLV in cells overexpressing dominant negative Vps4 E228Q 
protein [103], (C) RSV in cells treated with proteasome inhibitor MG-132 [104]. (D) 








have been described in retroviruses, containing the PT/SAP [100,101], PPxY [105,106], 
or YPxL/LxxLF [107,108] sequence motifs (Fig. 3D). Late budding defects caused by 
mutation of these motifs can be rescued by introduction of heterologous late domains. 
Moreover, late domains have been shown to retain their activity when transferred to 
different positions within Gag, suggesting that they function as docking sites for cellular 
factors rather than as essential structural elements [109,110]. Interestingly, several 
enveloped viruses encode multiple different late domain motifs in close proximity, with 
one usually playing a dominant role in promoting particle release [108,111,112]. Many 
aspects of late domain function have been elucidated over the past decade. The cellular 
binding partners of retroviral late domains have been described: PT/SAP domains recruit 
Tsg101 [103,113,114], LxxLF or YPxL domains recruit AIP-1/ALIX [108], and PPxY 
domains recruit Nedd4-like HECT ubiquitin E3 ligases [111,115-121]. All of these late 
domains require an intact cellular Class E vacuolar protein sorting (VPS) pathway to 
promote virion release [103,108,115,122-124]. 
 
Cellular vacuolar protein sorting machinery 
 The VPS pathway mediates the formation of intralumenal vesicles (ILVs) in 
multivesicular bodies (MVBs) (Fig. 4B), a process that involves membrane evagination 
away from the cytoplasm and is therefore topologically equivalent to viral budding. The 
pathway plays a critical role in the downregulation of activated cell surface receptors 
[125,126]. Endocytosed ligand-bound receptors can be either recycled to the plasma 
membrane or delivered to the lysosome (vacuole in yeast) for degradation. As late  
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Figure 4. Vacuolar protein sorting pathway. (A) Ubiquitinated cell surface receptors are 
internalized and delivered to endosomes, which also receive cargoes from the trans-Golgi 
network. As endosomes mature, vesicles bud into the lumen to form multivesicular 
bodies (MVBs). Some cargoes are recycled back to the plasma membrane, either directly 
or indirectly through recycling endosomes. Other cargos are sorted onto intraluminal 
vesicles, which eventually get degraded by proteolytic enzymes when multivesicular 
bodies fuse with lysosomes. Taken from Nickerson, et. al. EMBO Reports, 2007 [127]. 
(B) Transmission electron micrograph of a multivesicular body [128]. (C) Aberrant 
“Class E” compartment caused by Vps4 deletion in yeast [125]. 
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endosomes mature, soluble VPS factors are recruited to the limiting membrane, where 
they promote the formation and release of vesicles into the endosome lumen and regulate 
the sorting of proteins onto ILV membranes. Fusion of mature MVBs with the lysosome  
exposes the ILVs and their associated proteins to hydrolytic enzymes, resulting in their 
degradation. Proteins on the limiting membrane of MVBs remain intact and may 
subsequently get recycled to the cell surface (Fig. 4A). Disruption of the VPS machinery 
in yeast results in the formation of abnormally large, multilamellar ‘Class E’ 
compartments that lack intralumenal vesicles (Fig. 4C) and in the mislocalization of 
endocytic cargo proteins to the vacuolar membrane [125]. 
 Ubiquitin modification of endocytic cargo is a key signal for sorting onto 
intralumenal vesicles [126]. Ubiquitin is a small (76 residue) polypeptide, highly 
conserved among eukaryotes, that becomes covalently attached to other proteins by an 
isopeptide bond between the exposed carboxyl group of its C-terminal glycine residue 
and the ε-amino group of lysine residues in the substrate protein (reviewed in [129,130]). 
Since ubiquitin contains 7 lysine residues (Lys6, Lys11, Lys27, Lys29, Lys33, Lys44, 
and Lys63), it can itself serve as a substrate for ubiquitination, thus forming linear or 
branched ubiquitin chains [131]. Proteins can be mono- or polyubiquitinated on single or 
multiple lysine residues. Few instances of ubiquitin modification on non-lysine residues 
have also been reported [132,133]. Different types of ubiquitin modifications are 
selectively recognized by various cellular pathways and thus signal different fates for the 
substrate protein. Among the numerous functions of ubiquitin, the targeting of misfolded 
or damaged proteins for degradation by the 26S proteasome by K48-linked polyubiquitin 
chains is the best understood [134]. Lys11-linked ubiquitin chains have recently been 
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shown to direct endoplasmic reticulum-associated degradation (ERAD) [135]. 
Monoubiquitination of membrane receptors appears to be sufficient to signal entry into 
the MVB pathway; however, many endosomal cargos are modified by K63-linked or 
other types of polyubiquitin chains [126,136-138]. 
The Class E VPS machinery is highly conserved from yeast to humans, and 
genetic studies in yeast have been instrumental to the identification of many mammalian 
VPS factors and their interactions. The human vacuolar protein sorting (VPS) machinery 
consists of about 30 factors that form several multiprotein complexes, known as 
endosomal sorting complexes required for transport (ESCRTs) (outlined in Table 1 and 
Fig. 5, reviewed in [139]). The traditional model for ubiquitinated protein sorting 
proposes that ESCRT-I,  -II, and -III are recruited sequentially to the limiting membrane 
of MVBs by their interactions with each other and ubiquitinated cargo. ESCRT-III is 
thought to drive the membrane deformation and scission event required for vesicle 
budding into the lumen of MVBs [140,141]. The AAA ATPase Vps4 is required for 
ESCRT disassembly and VPS factor recycling after each round of vesicle formation and 
release [142,143]. 
ESCRT-I is thought to be responsible for recognition of ubiquitinated cargo and 
recruitment of downstream VPS components to endosomal compartments [126]. The 
major soluble form of the complex is a heterotetramer of Tsg101 (Vps23 in yeast), 
Vps28, Vps37, and MVB12, containing a single copy of each subunit [144,145]. ESCRT-
I is largely cytosolic, but relocalizes to aberrant endosmoal compartments induced by the 
loss of Vps4 activity, either by deletion of the Vps4 gene (in yeast) [126] or  
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Figure 5. Late domains recruit HECT ubiquitin ligases or components of the Class E 
vacuolar protein sorting (VPS) pathway. Direct protein-protein interactions are indicated 
by double ended arrows, and ESCRT-I, -II, and -III complexes are highlighted in yellow, 
green, and red, respectively. Adapted from Bieniasz, Virology, 2006 [85] 
 
overexpression of the catalytically inactive Vps4 mutant protein (in mammalian cells) 
[146]. Tsg101 can bind ubiquitinated MVB cargo proteins through its ubiquitin E2  
variant (UEV) domain, which structurally resembles E2 ubiquitin conjugating enzymes 
but lacks a conserved cysteine residue essential for catalytic activity [147,148]. Tsg101 
also forms a ternary complex with Vps28 and Vps37 via its C-terminal domain [149]. 
Vps28, in turn, interacts with ESCRT-II through its C-terminal domain and may thus 
mediate its recruitment to membrane domains enriched with MVB cargo [150]. 
Expression of Tsg101, Vps28, and Vps37 is essential for MVB biogenesis and cargo 
sorting [126,146,149]. The recently identified Mvb12 protein interacts with the Tsg101-
Vps37 binary complex [145] and modulates ESCRT-I function [145,151-153]. The C-
terminus of yeast Mvb12 appears to contain a ubiquitin-binding domain [154]. Though 
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Mvb12 is not strictly required for MVB sorting, it appears to prevent premature binding 
of ESCRT-I to ESCRT-II and facilitate its dissociation from cargo, thus preventing its 
encapsulation within vesicles that bud into the MVB lumen [152]. Mvb12 may also 
function in cargo selection, as it appears to enhance ubiquitin-independent cargo sorting 
into the yeast vacuole [153]. 
 
Table 1. Class E vacuolar protein sorting factors in yeast and mammals 
 















Snf7 (Vps32) CHMP4A/B/C 








 Efficient recruitment of ESCRT-I to endosomal compartments appears to require 
another complex, sometimes referred to as ESCRT-0, which includes Hrs (Vps27) and 
STAM (Hse1) proteins [155,156]. Hrs has been shown to be important for ligand-
dependent lysosomal degradation of platelet-derived growth factor (PDGF) receptor and 
epidermal growth factor receptor (EGFR), and its depletion from cells induces the 
formation of enlarged endosomes [155]. Hrs contains a FYVE domain, which 
preferentially binds PI(3)P-containing membranes, and a coiled-coil domain, which 
mediates its association with STAM and contributes to membrane binding [155,157]. 
Moreover, the central region of Hrs contains a PSAP motif, which is essential for its 
interaction with Tsg101 [157-159]. Hrs thus recruits STAM and ESCRT-I to early 
endosomal membranes [155,157,158]. The Hrs-STAM complex can directly associate 
with ubiquitin via three ubiquitin binding sites in Hrs  (one double-sided UIM and one 
VHS motif) and two in STAM (one UIM and one VHS) [155,156,160,161]. Mammalian 
Hrs also interacts with Eps15, another UIM-containing protein [155]. Mono- and poly-
ubiquitination of membrane proteins serves as a key determinant for their targeting to the 
lysosome lumen during the critical sorting step in the MVB. Despite the low affinity of 
individual UIMs and VHS motifs for monoubiquitin, multivalent ubiquitin binding by 
ESCRT-0 allows it to interact with ubiquitinated cargo with strong avidity [161]. Indeed, 
ubiquitinated proteins have been shown to co-localize with Hrs and STAM on endosomal 
membrane microdomains [155]. Thus, ESCRT-0 appears to concentrate ubiquitinated 
cargo on endosomes while recruiting downstream ESCRT components that mediate 
endosome maturation by inducing the formation of intralumenal vesicles. 
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 ESCRT-II is a stable soluble complex that functions downstream of ESCRT-I 
[162]. The complex is a trilobal tetramer, consisting of two copies of EAP20 (Vps25) 
bound to single copies of Eap30 (Vps22) and EAP45 (Vps36) [163,164]. Deletion of any 
ESCRT-II component in yeast induces the formation of an aberrant Class E compartment 
that accumulates endosomal cargo [162]; however, ESCRT-II does not appear to be 
universally required cargo sorting in mammals [165]. EAP45 can efficiently bind 
phosphoinositide-3-phosphates and can, therefore, independently mediate ESCRT-II 
recruitment to endosomal membranes [150,162,166]. Mammalian EAP45 can bind 
ubiquitin via its N-terminal GLUE domain [166], and both EAP30 and EAP45 have the 
capacity to bind the C-terminal “steadiness box” of Tsg101 [167]. In contrast, the yeast 
homolog of EAP45, Vps36, simultaneously mediates ESCRT-II association with 
membranes, ubiquitin, and ESCRT-I. The GLUE domain of Vps36 contains two NZF 
zinc fingers, one of which binds ubiquitin and the other Vps28 [150]. EAP20 mediates 
ESCRT-III recruitment by interacting with the basic N-terminal domain of CHMP6 
(Vps20) [150,162,167,168]. 
 ESCRT-III comprises the core machinery of MVB biogenesis that executes the 
membrane deformation and scission events required for intralumenal vesicle formation 
[140,141,169]. ESCRT-III proteins exist as soluble monomers in the cytosol, held 
together in a “closed” autoinhibited conformation by association of their basic amino 
terminal portion with the highly acidic carboxy terminal portion [124,170,171]. CHMP6 
contains a myristoylation signal that allows it to independently bind endosomal 
membranes [170]. Interaction of EAP20 with CHMP6 on endosomes induces a 
conformational change in CHMP6, thus activating it to nucleate CHMP4 (Snf7) 
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oligomerization [169,171,172]. ESCRT-II, therefore, appears to function as a scaffold for 
ESCRT-III assembly. Overexpressed CHMP4 can polymerize in circular membrane-
associated filamentous arrays that deform the membrane away from the cytoplasm [140]. 
Interestingly, ESCRT-II containing a single EAP20 arm can promote CHMP4 
oligomerization but cannot support MVB sorting, suggesting that membrane evagination 
may require lateral interactions between multiple ESCRT-III filaments [172]. CHMP3 
(Vps24) terminates CHMP4 oligomerization and recruits CHMP2 (Vps2), which in turn 
recruits Vps4 by interactions with its MIT domain [171]. Incubation of spherical 
liposomes with all four yeast ESCRT-III components in vitro induces the formation of 
inward invaginations, or buds, which are reversed by addition of Vps4 and ATP. Vps2 
(CHMP2) is required for complete detachment of these buds from the limiting 
membrane, while Vps4 and ATP are required for subsequent rounds of intralumenal 
vesicle formation [141]. Thus, ESCRT-III mediates membrane scission, and Vps4 allows 
recycling of ESCRT components. 
 The mammalian ESCRT pathway appears to have a redundant or alternative 
mechanism for ESCRT-III recruitment. AIP1/ALIX binds CHMP4 proteins and contains 
a PTAP motif, which mediates its interaction with the Tsg101 UEV domain 
[108,122,123]. ALIX thus effectively bridges ESCRT-I with ESCRT-III. Bro1, the yeast 
homolog of ALIX, interacts directly with Snf7 but lacks a PTAP-like motif and, therefore 
cannot mediate the recruitment of ESCRT-III to ESCRT-I. Instead, it appears to function 
as an adaptor for the deubiquitinating enzyme Doa4, whose recruitment to budding 
vesicles allows the recycling of ubiquitin from cargo proteins before they become 
sequestered within ILVs [173,174]. Similarly, mammalian ESCRT-III components 
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recruit deubiquitiniating enzymes AMSH and UBPY to endosomal compartments, where 
their catalytic activity is stimulated by interaction with STAM [175]. 
 The Vps4 AAA-type ATPase mediates the dissociation of ESCRT components 
from membranes. Recruitment of ATP-bound Vps4 dimers to endosomal membranes is 
thought to result in the formation of higher order Vps4 oligomers (hexameric rings) in 
association with ESCRT complexes via coiled-coil interactions [176]. Oligomerization 
then triggers the ATPase activity of Vps4, inducing a comformational change that 
destabilizes the complexes, resulting in ESCRT and Vps4 disassembly and dissociation 
from the membrane [142]. The catalytic activity of Vps4 may also be modulated by 
interaction with ESCRT-III and other cellular proteins, including LIP5 and Ist1 [177-
182]. One model for ESCRT disassembly suggests that ESCRT-III proteins associate 
with the central pore of the Vps4 ring in the bud neck of nascent vesicles and are shunted 
through the pore into the cell interior by conformational changes induced by the ATP 
hydrolysis cycle [176,182-184]. The loss of Vps4 catalytic activity causes VPS proteins 
to become trapped on endosomal membranes, resulting in profound defects in MVB 
biogenesis and cargo sorting [125,142]. 
 The ability of ESCRT-III to induce membrane deformation has been challenged 
by a recent study, in which yeast MVB biogenesis was reconstituted in vitro using giant 
unilamellar vesicles (GUVs) [185]. Co-assembly of grossly overexpressed ESCRT-III 
proteins underneath a membrane into an interior coat can induce membrane curvature and 
bud formation [140,141,169]. However, intralumenal vesicles formed by such a 
mechanism would, in principle, consume ESCRT components [141] and deliver them to 
the lysosome lumen for degradation. At physiological concentrations, ESCRT-III cannot 
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induce ILV formation on its own. Instead, ESCRT-I and ESCRT-II together deform GUV 
membranes to produce open buds in the absence of cargo or other ESCRT components. 
The two complexes localize to the bud neck, and therefore appear to stabilize it, without 
entering the bud themselves (Fig. 6B [185]). ESCRT-0 seems to possess an intrinsic 
capacity to cluster and concentrate ubiquitinated cargo on membrane patches (Fig. 6A 
[155,185]). ESCRT-I recruits ESCRT-0 to the bud neck [157-159], presumably allowing 
it to deposit ubiquitin-bearing cargo into the forming intralumenal vesicles (Fig. 6B 
[185]). Meanwhile, ESCRT-II recruits ESCRT-III proteins to the bud neck [185], 
nucleating the assembly of Snf7 into an interior collar (Fig. 6C [172]) and allowing 
membrane scission by Vps2 to release the nascent vesicle into the GUV lumen (Fig. 6D 
[141]). While ubiquitinated cargo localizes to intralumenal vesicles, ESCRT components 
remain at the bud neck [185], where they can be recycled by Vps4 ATPase activity 
[141,169]. 
 Another recent study has challenged the model of sequential handover of 
ubiquitinated cargo from ESCRT-0 to ESCRT-I, -II, and -III [154]. Disruption of 
ubiquitin binding by either ESCRT-I or ESCRT-II was insufficient to inhibit cargo 
sorting to the vacuole in yeast. Simultaneous disruption of ubiquitin binding by both 
complexes impaired sorting of some cargos. Complete inhibition of MVB sorting 
required disruption of ESCRT-I and ESCRT-II ubiquitin binding and ablation of ESCRT-
I interaction with ESCRT-0, suggesting that the complexes provide parallel mechanisms 






































Figure 6. Molecular model for MVB biogenesis. (A) ESCRT-0 self-assembles and 
clusters ubiquitinated cargos on endosomal membranes. (B) ESCRT-I and -II deform the 
membrane into a bud and stabilize the bud neck. ESCRT-I recruits ESCRT-0, facilitating 
deposition of cargo into the bud. (C) ESCRT-II nucleates assembly of ESCRT-III 
components in the bud neck into an interior collar. (D) ESCRT-III mediates membrane 
scission to release the nascent vesicle into the endosome lumen. ESCRT components 
remain on the outside of the limiting membrane until they are recycled by Vps4. Taken 
from Wollert and Hurley, Nature, 2010 [185]. 
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The ESCRT pathway mediates multiple topologically similar membrane scission 
events 
Recently, the ESCRT pathway has been implicated in mediating the plasma 
membrane abscission event of cytokinesis, required for separation of daughter cells from 
each other. Tsg101 and ALIX localize to the midbody, a constricted membrane structure 
between the daughter cells, and their interaction with Cep55 is essential for the resolution 
of the membrane tether [186,187]. Tsg101 binding to ESCRT-I component Vps28 [186] 
and ALIX-mediated recruitment of ESCRT-III proteins to the midbody are also important 
for cytokinesis [187,188]. Moreover, overexpression of ESCRT-III proteins or 
catalytically inactive Vps4 inhibits cytokinesis [186,187,189]. Importantly, the role of 
ESCRT proteins in cell division appears to be direct and independent of endosomal 
protein sorting, since catalytic activity of Vps4 is required for cytokinesis in archaea, a 
separate domain of life that lacks endosomal membranes [190,191]. 
The Class E VPS machinery executes a membrane fission event common to three 
functionally distinct but topologically equivalent processes (Fig. 7). The membrane 
deformation activity of ESCRT proteins is commonly thought to be dispensable for viral 
budding, since Gag multimerization on membranes appears to have an intrinsic capacity 
to induce membrane curvature [192]. However, late domain mutation in some 
retroviruses, including Mason-Pfizer monkey virus (MPMV) and murine leukemia virus 
(MLV), has been demonstrated to induce early budding defects, manifested by aberrant 
or inefficient assembly [110,193,194]. 
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Figure 7. The ESCRT machinery mediates three topologically similar membrane scission 
events: (1) budding of vesicles into the lumen of multivesicular bodies, (2) late domain-
dependent separation of nascent enveloped virions from the host cell, and (3) abscission 
of the plasma membrane between two daughter cells during cytokinesis. Taken from 
Wollert, et. al., J. Cell Science, 2009 [195]. 
 
As previously mentioned, retroviruses rely on cis-acting elements, called late 
domains, within their structural Gag proteins to co-opt the cellular vacuolar protein 
sorting pathway. Inhibition of the Class E pathway by expression of dominant negative  
Vps4 or ESCRT-III components potently blocks the late stage of virion production by 
retroviruses encoding diverse late domains [103,108,113,115,122-124,196]. Viruses 
containing YPxL- or LxxLF-type late domains, such as EIAV, engage the Class E 
pathway by recruiting ALIX [108], which can in turn recruit the core membrane scission 
machinery of ESCRT-III through its direct interaction with CHMP4 proteins [197]. 
Indeed, the Bro1 domain of ALIX, which mediates this interaction, is essential for its 
ability to mediate late domain-dependent budding [196,198]. Viruses encoding PT/SAP-
type late domains, including HIV-1, recruit Tsg101 [103,113,114], a core component of 
ESCRT-I, which can recruit ESCRT-III indirectly through interactions with ALIX 
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[108,122,123,196] or ESCRT-II [123,150,167,168]. Moreover, HIV-1 has been reported 
to specifically package Tsg101, Vps28, ALIX, and Vps4 inside virions [108,123]. In 
contrast, viruses encoding PPxY-type late domains, such as murine leukemia virus 
(MLV) and Rous sarcoma virus (RSV), recruit Nedd4-like HECT ubiquitin E3 ligases, 
which have no known binding partners in the Class E pathway [111,115-121].  
 
HECT ubiquitin ligase biochemistry and functions 
 HECT ligases play an important role in directing the substrate specificity of the 
cellular ubiquitylation cascade. Ubiquitin conjugation is a multistep process, involving 
the sequential transfer of ubiquitin from an E1 activating enzyme to E2 conjugating 
enzymes, then to E3 ligating enzymes, and finally to substrate proteins (reviewed in 
[129]). The E1 enzyme initiates the cascade by adenylating the carboxy terminus of 
ubiquitin with ATP and then attacking the resulting high-energy anhydride bond with the 
sulfhydryl group of its catalytic cysteine to generate an E1-Ub intermediate. The E2 
enzyme, in turn, attacks the high-energy thioester bond linking ubiquitin to the E1 
enzyme using its own catalytic cysteine, thus transferring the ubiquitin moiety to its own 
active site. Finally, the E3 ligase promotes the transfer of ubiquitin from the E2 to a 
specific substrate. Eukaryotes express two classes of E3 ubiquitin-protein ligases that 
function via distinct mechanisms. RING family E3 ligases lack intrinsic enzymatic 
activity and function primarily as scaffolds that position the reactive E2-Ub thioester 
bond in close proximity to the nucleophilic amino group of the target lysine residue on 
the substrate protein [199]. In addition, RING ligases may trigger conformational 
changes in the E2 to stimulate ubiquitin release, thus facilitating its transfer [200]. In 
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contrast, the active site of HECT family E3 ligases contains an essential cysteine residue 
that forms a direct thioester bond with ubiquitin before catalyzing its transfer to the 
substrate [201]. 
 Humans encode 28 known HECT ubiquitin E3 ligases [202], a subset of which 
has been grouped into two families based on shared domain organization: the Nedd4 
family contains nine members (Fig. 8B), and the HERC family contains six members. 
Nedd4-like HECT ligases contain an N-terminal C2 domain, two to four WW domains, 
and a C-terminal HECT domain (Fig. 8A). The C2 domain binds phosphoinositides and 
mediates ligase recruitment to the plasma membrane and endosomal membranes 
[203,204]. The WW domains contain WxxP repeats that bind PPxY motifs in substrate 
and adapter proteins [205]. The HECT domain mediates catalysis, using a conserved 
cysteine residue near its C-terminus [201,206]. HERC family members contain a catalytic 
HECT domain and one or more regulator of chromosome condensation 1 (RCC1)-like 
domains (RLDs), which bind chromatin and may possess guanine nucleotide-exchange 
factor (GEF) activity [207,208]. The remaining HECT ligases possess various domains in 
addition to HECT, including zinc fingers, UBA domains, ankryn repeats, and RING 
fingers [209]. HECT ligases perform important regulatory roles in diverse cellular 
processes, such as endocytosis, endosomal trafficking, chromatin remodeling, and gene 
expression, and their malfunction has been associated with numerous physiological 
disorders, including cancers, autoimmunity, hypertension, and developmental defects 




















Figure 8. Nedd4-like HECT ubiquitin E3 ligases. (A) Typical domain organization of 
Nedd4 family members. (B) Phylogenetic tree of the nine human Nedd4-like HECT 
ligases. (C) Structure of the HECT domain of WWP1. The N-lobe (blue, residues 546–
802) is connected to the C-lobe (magenta, residues 546-802) by a short flexible hinge 







 The catalytic domains of HECT ligases contain two distinct polypeptide lobes 
connected by a hinge loop (Fig. 8C). The elongated N-lobe binds E2 enzymes, while the 
smaller C-lobe contains the residues critical for catalysis. Hinge loop flexibility is 
required for catalytic activity, presumably because the C-lobe must rotate with respect to 
the N-lobe, in order to align its catalytic cysteine either with the E2-bound ubiquitin or 
with the lysine acceptor residue on the substrate [210]. A highly conserved phenylalanine 
residue near the C-terminus of HECT domains is dispensable for thioester bond 
formation between ubiquitin and the catalytic cysteine but essential for the subsequent 
ubiquitin transfer to the substrate [211,212]. Several HECT domains possess a non-
covalent ubiquitin-binding site in the N-lobe, which appears to regulate the length of and, 
possibly, linkage types in the synthesized ubiquitin chains. The ubiquitin-interacting site 
of mammalian Smurf2 HECT contributes to efficient binding of monoubiquitinated 
substrates and is required for polyubiquitination [213]. In contrast, the analogous binding 
site in yeast Rsp5 HECT seems to limit ubiquitin chain elongation [214].  
 Although isolated HECT domains are thought to be constitutively active, HECT 
ligases have evolved various mechanisms to regulate their catalytic activity. These 
mechanisms limit HECT ligase promiscuity and protect the ligases themselves from 
excessive autoubiquitination and consequent degradation. For example, intramolecular 
interactions between the C2 and HECT domains of Smurf2 inhibit its activity by 
obstructing the catalytic cysteine. Similar autoinhibitory interactions have been observed 
in WWP2 and Nedd4 [212]. The Smad7 adapter protein relieves Smurf2 autoinhibition 
by displacing the C2 domain from the N-lobe of the HECT domain and further stimulates 
catalytic activity by recruiting the UbcH7 E2 enzyme [212,215]. Itch and Nedd4L ligases 
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are autoinhibited by intramolecular interactions between their WW and HECT domains 
[216,217]. JNK1 kinase relieves Itch autoinhibition by phosphorylating the proline-rich 
region of the HECT domain, thereby destabilizing its association with the WW domains 
[217]. Autoinhibition of Nedd4L is likely relieved by substrate binding to its WW 
domains [216]. Deubiquitinating enzymes can antagonize the activity of some processive 
HECT ligases, such as yeast Rsp5, by partially disassembling their ubiquitin chains to 
produce mono- and oligo-ubiquitinated substrates [218]. In addition HECT ligase activity 
can be both positively and negatively regulated at the substrate recognition level by 
adaptors that facilitate or compete with substrate binding to WW domains [219-224]. 
 The yeast HECT ligase Rsp5 has been implicated in mediating both ubiquitin-
dependent and -independent cargo sorting into the MVB pathway. Rsp5 expression is 
dispensable for MVB biogenesis, but its deletion is associated with reduction in the 
average size of intralumenal vesicles [225]. Direct interaction of the endosomal cargo 
protein Sna3 with Rsp5 via an essential PPAY motif is required for its delivery to the 
vacuole; however, ubiquitination of Sna3 appears to be dispensable for its sorting [225-
227]. Remarkably, the catalytic activity of Rsp5 is essential for efficient sorting of lysine-
free Sna3, which does not become ubiquitinated [226,227]. Therefore, Rsp5 may promote 
MVB sorting of non-ubiquitinated cargo by ubiquitinating either itself or unknown 
adaptor proteins. 
 
HECT ligases and ubiquitin in retroviral budding 
The catalytic activity of several HECT ubiquitin ligases is essential for their 
ability to promote PPxY-dependent virus budding [115,120]. Additionally, 
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overexpression of the ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) has 
been reported to suppress PPxY-dependent Ebola VLP production by inhibiting the 
catalytic activity of Nedd4 [228,229]. Overexpression of catalytically inactive HECT 
ligases inhibits PPxY-dependent budding of murine leukemia virus (MLV), MPMV, and 
Ebola virus [115,120]. Truncated WWP1, lacking the entire catalytic domain, inhibits 
MLV budding more potently than full length WWP1 with a disrupted active site [115], 
suggesting that HECT domains may possess activities other than ubiquitin conjugation, 
such as cofactor recruitment, that are important for their function in viral budding. 
Consistent with this notion, HECT domains localize to membranes of aberrant ‘Class E’ 
compartments induced by overexpression of catalytically inactive ATPase Vps4 [115]. 
Since many VPS factors are trapped on Vps4-induced compartments, HECT domains 
may be recruited to these membranes by interaction with VPS proteins, either directly or 
through unidentified bridging factors. Interestingly, two recent studies have demonstrated 
significant stimulation of virion production by HIV-1 Gag lacking known late domains 
by overexpression of the HECT ligase Nedd4L. The rescue required the catalytic activity 
of Nedd4L, expression of Tsg101, and an intact Class E pathway and was accompanied 
by an increase in the ubiquitination of ESCRT-I components [230,231]. However, direct 
association between HECT ligases and ESCRT proteins has not been demonstrated. 
Multiple lines of evidence suggest a more general role of ubiquitin in retroviral 
budding. For example, free ubiquitin is enriched in retrovirus particles [232,233], and low 
levels of mono or oligo-ubiquitinated Gag have been detected in HIV-1 virions [234]. 
Furthermore, proteasome inhibitors block the release of retroviruses that encode PT/SAP 
or PPxY late domains, most likely by depleting free ubiquitin from cells 
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[104,116,235,236]. Since ubiquitination of cellular proteins can serve as a signal for 
MVB sorting by recruiting ESCRT proteins, deposition of ubiquitin on viral structural 
proteins may also lead to engagement of the class E machinery. Consistent with this 
notion, fusion of ubiquitin to the PTAP-encoding late domain of HIV-1 Gag significantly 
enhances its affinity for the Tsg101 UEV domain, despite the inherently weak affinity of 
the UEV domain for monoubiquitin alone [103]. Moreover, mutation of multiple 
ubiquitin acceptor lysine residues in Gag has been shown to inhibit particle production by 
several retroviruses [237,238]. 
 To address whether ubiquitination of viral proteins is generally required for 
enveloped viral particle release we took advantage of an unusual retroviral Gag protein 
that is almost devoid of lysines. We found that VLP release proceeded efficiently in the 
absence of ubiquitin acceptors in the viral protein, when dependent on a motif (PSAP) 
that directly recruits the ESCRT machinery. Remarkably, when particle release was 
engineered to be dependent on a PPxY motif and a catalytically active ubiquitin ligase, 
ubiquitin acceptors in the viral protein remained dispensable. Thus, ubiquitin-dependent 
release of enveloped viral particles appears to involve ubiquitin conjugation to trans-
acting factors rather than directly to viral proteins. We also showed that the catalytic 
activity of different HECT domains is essential for their ability to promote PPxY-
dependent VLP release. However, stimulation of budding correlated directly with 
autoubiquitination of HECT domains rather than their ability to ubiquitinate Gag. 
Moreover, direct fusion of a single ubiquitin moiety to the C-terminus of PFV Gag was 
sufficient to promote both late domain-dependent and -independent budding. The ability 
of ubiquitin to effectively compensate for the lack of conventional late domain function 
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required the Ile44 hydrophobic patch of ubiquitin and an intact cellular VPS pathway. 
Our results support a model for HECT ligase-mediated viral budding, whereby the 
stimulation of protein ubiquitination in the vicinity of VLP assembly promotes the 
concentration of ubiquitin-interacting Class E proteins and consequent recruitment of the 




































Chapter II. Materials and Methods 
 
Construction of membrane-targeted PFV Gag expression plasmids 
The PFVΔEnv proviral plasmid and the PFV Env expression plasmid have been 
described previously, and were a gift from A. Rethwilm [239]. The wild-type and mutant 
(PSAP284-287AAAT) PFV Gag open reading frames were amplified from corresponding 
proviral PFV plasmids, that have been previously described [240], using primers directed 
to the 5’ and 3’ termini of the PFV Gag coding sequence and appended with NcoI and 
XhoI restriction enzyme sites, respectively. These amplicons were inserted into an 
NcoI/XhoI digested pCAGGS expression vector, to generate pCAGGS/Gag and 
pCAGGS/Gag(PTAP-) respectively. Membrane targeted Gag expression plasmids were 
derived from pCAGGS/Gag by inserting annealed oligonucleotides encoding the peptides 
MyrR (MGARASGSGRRRGSGRRR), Fyn (MGCVQCKDKE), FynR 
(MGCVQCRDRE), and Lck (MGCGCSSHPE) into the NcoI site at the 5’ end of PFV 
Gag. Lysine-free PFV Gag proteins were generated by Lys396 to Arg by PCR based 
mutagenesis. The pCAGGS/Gag(ASAP) expression plasmid was derived from 
pCAGGS/Gag  by PCR based mutagenesis. pCAGGS plasmids expressing Lck-Gag-PY, 
Lck-Gag-PY-3K, or Lck-Gag-PSAP-PY were constructed by inserting the MLV late 
domain with or without three appended lysine residues (LLTEDPPPYRD [KKK]) at the 
3’ end of Lck-Gag(K396R) using long PCR primers directed to the C-terminus of Gag. 
Plasmids expressing cyan-fluorescent fusions of PFV Gag proteins were constructed by 
inserting cerulean fluorescent protein encoding sequence into the 3’ XhoI site of all 
pCAGGS/PFVGag derivatives. pCAGGS/Gag-UbΔGG expression plasmids were 
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generated by overlap PCR, using pCAGGs/Gag(PSAP), pCAGGS/Gag(PSAP-), and 
pCAGGS/Gag(PSAP-PY) as templates for the N-terminal portions and pHA-ubiquitin as 
the template for the C-terminal portion. The K48R, K63R, F4A, L8A, I44A, and 
QE62,64AA point mutations were introduced into Lck-PFV Gag-PSAP-Ub and Lck-PFV 
Gag-ΔPSAP-Ub constructs by PCR-based mutagenesis. Each cDNA was cloned into 
pCAGGs for expression in mammalian cells. 
 
Construction of chimeric HECT ligase expression plasmids 
Plasmids expressing WWP1, WWP2, Nedd4, Nedd4L, Itch, Smurf1, and Rsp5 have been 
described previously [115,225]. The Bul2 HECT domain (encoding residues 1189-1572) 
was PCR amplified from 293T cell cDNA. Chimeric HECT ligases containing the C2 and 
WW domains of WWP1 and heterologous HECT domains were constructed by overlap 
PCR and cloned into the pCR3.1/YFP expression vector, fused to the C-terminus of YFP, 
as outlined in Table 2. Plasmids expressing catalytically inactive WWP1 (C890S) and 
Rsp5 (C777S) have been described previously [115,225], and Rsp5 (C777S) was used as 
a template to generate the catalytically inactive WWP1/Rsp5 expression plasmid. 
Plasmids expressing catalytically inactive chimeric ligases were generated by introducing 
the following point mutations into wild type chimeric ligases by PCR mutagenesis: 






































































Construction of chimeric Tsg101/HECT expression plasmids  
The Tsg101 expression plasmid has been described previously [113,241]. Tsg-HECT and 
WWP1-TsgΔUEV chimeras were generated by overlap PCR, using full length Tsg101, 
WWP1, Nedd4L, and Itch as templates, as outlined in Table 3. The amplicons were then 
cloned into EcoRI/NotI-digested pCR3.1/YFP expression plasmids, fused to the C-
terminus of YFP. Point mutations to inactivate the catalytic domain of each Tsg-HECT 









































Additional expression plasmids 
The HIV-1 HXB ΔPTAP proviral plasmid has been described previously [113]. Yeast 
two-hybrid plasmids encoding wild type and I44A ubiquitin were constructed by PCR 
amplification of ubiquitinΔGG from the pHA-ubiquitin plasmid using 5’ and 3’ primers 
appended with EcoRI restriction sites and cloning into the pGBKT7 (Clontech) and 
pVP16 vectors [113]. The Class E factor yeast two-hybrid library, encoding a panel of 
Class E VPS factors in pGBKT7 and pVP16 backgrounds, has been described [122]. 
pCR3.1-based expression plasmids encoding fluorescent fusions of WWP1ΔHECT, Vps4 
E228Q, Tsg101UEV, Hrs, ALIX, UBPY, and Eap45 have been described previously 
[113,115,122,241]. The following mutants, impaired for ubiquitin binding, were 





Cell lines and transfections 
293T and HeLa cell lines were cultured in DMEM supplemented with 10% fetal bovine 
serum and 10µg/ml gentamycin (Gibco). For 293T cell transfections, plasmids were 
mixed in 100µl serum-free DMEM, followed by addition of 4µg PEI (Polyethylenimine; 
Polysciences) per 1µg total DNA (from a 1mg/ml PEI stock solution). This mixture was 
vortexed briefly and incubated at room temperature for 15 minutes before addition to 
cells. Transfections were allowed to proceed for 4 hours before replacing with fresh 
media. For HeLa cell transfections, plasmids were mixed in 100µl serum-free DMEM 
and vortexed briefly. A master mix containing 100µl serum-free DMEM and 5µl 
Lipofectamine 2000 (Invitrogen) per reaction was prepared, mixed gently by pipetting, 
and incubated at room temperature for 5 minutes. The Lipofectamine 2000 mixture 
(105µl) was then added to the plasmid mixture and incubated at room temperature for 15 
minutes before addition to cells. Transfections were allowed to proceed for 4 hours 
before replacing with fresh media. 
 
Western Blot Analysis  
Virion and cell lysates and immunoprecipitates were separated on polyacrylamide gels, 
transferred to nitrocellulose membranes, and probed with various antibodies: anti-PFV 
human serum, anti-HIV-1 p24CA (183-H12-5C), anti-EIAV equine serum (VMRD, Inc.), 
anti-GFP (Roche), and anti-HA (HA.11, Covance). Subsequently, the blots were probed 
with species-specific peroxidase-conjugated secondary antibodies and chemiluminescent 
substrate reagents (Pierce) for conventional Western blotting. Alternatively, membranes 
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were probed with species-specific antibodies conjugated to IRDye800CW, and 
fluorescent signals were detected and quantified using a LICOR Odyssey scanner. 
 
Virus particle release assay 
 PFV Gag VLP release assays were performed either in 100mm plate or 6-well 
plate formats. In 100mm plates, 293T cells were seeded at 3 × 106 cells per plate and 
transfected the following day with 2µg pCAGGS/Gag plasmids, alone or with 4µg 
pCR3.1/YFP, pCR3.1/YFP-WWP1, or a derivative. Virus-like particles were pelleted by 
ultracentrifugation of 8ml 0.22-µm-filtered culture supernatants, collected 24 hours post-
transfection, over a 4ml 20% sucrose cushion for 2 hours at 100,000 × g. In 6-well plates, 
293T cells were seeded at 5 × 105 293T cells per well and transfected the following day 
with 1µg of pCAGGs/PFVGag-derived plasmids, alone or with 1µg of pCR3.1/YFP, 
pCR3.1/YFP-WWP1-HECT, pCR3.1/YFP-TsgUEV-HECT, or pCR3.1/YFP-WWP1-
TsgΔUEV plasmids. Alternatively cells were transfected with 1µg of pCAGGs/PFVGag-
derived plasmids and the indicated amounts of fluorescent Class E factor expression 
plasmids. Virus-like particles were pelleted by ultracentrifugation of 2ml 0.22-µm-
filtered culture supernatants, collected 48 hours post-transfection, over a 2ml 20% 
sucrose cushion for 90 min at 115,000 × g. 
 HIV-1 and EIAV VLP release assays were performed in 6-well plates. 293T cells 
were seeded at 5 × 105 293T cells per well and transfected with 500ng of pCR3.1/HIV-
1Gag or pCR3.1/EIAVGag expression plasmids or HIV-1 HXB-ΔPSAP proviral plasmid 
and the indicated amounts of fluorescent Class E factor expression plasmids. VLPs were 
pelleted by ultracentrifugation of 2ml of 0.22-µm-filtered culture supernatants, collected 
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48 hours after transfection, over a 2-ml 20% sucrose cushion for 90 min at 115,000 × g. 
VLP and cell lysates were analyzed by conventional or quantitative Western blotting. 
 
Ubiquitin transfer assay 
293T cells (5 × 105) in six-well plates were cotransfected with 1 µg of 
pCAGGs/PFVGag-PY-3K, 500 ng of pHA-ubiquitin, and 1 µg of the indicated chimeric 
pCR3.1-WWP1-HECT ligases. At 36 hours after transfection, each well of cells was 
thoroughly lysed at room temperature with 400µl of denaturing lysis buffer (50mM Tris 
pH 7.4, 150mM NaCl, 1mM EDTA, 1.0% glycerol, 0.5% SDS, supplemented with 
protease inhibitor tablets (Roche) and 5mM N-ethylmaleimide to inhibit 
deubiquitination), sonicated, and cleared of cellular debris by microcentrifugation at 
14,000 rpm for 10min. The lysates were then diluted 5-fold, to adjust the concentration of 
SDS to 0.1% and NP-40 to 1.0%, and split into two fractions. From one fraction, Gag 
proteins were immunoprecipitated with αPFV serum and protein G-Sepharose beads. 
From the other fraction, YFP-HECT ligase proteins were immunoprecipitated with αGFP 
monoclonal antibody and protein G-Sepharose beads. The beads were washed three times 
with RIPA buffer (50mM Tris pH 7.4, 150mM NaCl, 1mM EDTA, 0.1% SDS and 1.0% 
NP-40), and proteins were eluted from the beads by boiling for 10 minutes in 2x SDS 
protein sample buffer, supplemented with 2% 2-mercaptoethanol. Immunoprecipitates 
and unfractionated cell lysates were then analyzed by conventional chemiluminescent or 





HeLa cells (4 × 105) on 35-mm poly-D-lysine coated glass bottom dishes (Mattek) were 
cotransfected with plasmids expressing CFP-fused and unfused Lck-Gag at a 1:1 ratio, 
either alone or along with 200 ng pCR3.1/YFP-WWP1-WW. Twenty-four hours post 
transfection cells were fixed in paraformaldehyde and visualized by deconvolution 
microscopy using an Olympus IX70-based DeltaVision system (Applied Precision) 
equipped with a 100× magnification oil immersion objective and a Photometrics CH350L 
camera. Optical filters were used to distinguish YFP and CFP fluorophores. For each 
condition, a stack of 30 images spaced by 0.3µm in the Z-dimension was acquired and 
deconvolved using SoftWorx software (Applied Precision), and single optical sections at 
the center of the cell and at the cell-coverslip interface were selected. 
 
Electron microscopy 
Electron micrographs of assembling Lck-PFV virus-like particles were generated by 
Marc C. Johnson (Department of Molecular Microbiology and Immunology, University 
of Missouri). Briefly, DF-1 cells were transfected with plasmids expressing GFP-VPS4 
(E228K) along with Lck-Gag, or MLV GagPol along with pdsRED, and fixed in 
paraformaldehyde. After fluorescence imaging, cells were fixed in glutaraldehyde, 
postfixed in osmium tetroxide, dehydrated in ethanol, critical point-dried, and sputter-
coated with gold palladium. Cells were identified by their location on a finder grid and 




Yeast two-hybrid assay 
Yeast cells (Y190) were transformed with 1µg each of the pGBKT7- and pVP16-derived 
plasmids described above. Cells transformed with pGBKT7 plasmids expressing each 
class E factor were co-transformed with either empty pVP16 vector, pVP16-Ub or 
pVP16-Ub(I44A). Alternatively, cells transformed with pVP16 plasmids expressing each 
class E factor were co-transformed with either empty pGBKT7 vector, PGBKT7-Ub, or 
pGBKT7-Ub(I44A). Double transformants were selected on supplemented agar plates 
lacking leucine and tryptophan. After two days, yeast pellets consisting of 10-20 colonies 
were resuspended in 0.5ml Z-buffer (60mM Na2HPO4, 40mM NaH2PO4, 10mM KCl, 
1mM MgSO4, 0.28% 2-mercaptoethanol, 0.01% SDS) and permeabilized by addition of 
25µl chloroform and vortexing. Protein-protein interactions were assayed by β-
galactosidase reporter activity. The β-galactosidase substrate chlorophenol red-β-D-
galactopyranoside (CPRG, Roche) was added to a final concentration of 1.4mg/ml, and 
the suspensions were mixed by vortexing and incubated at room temperature for 30 
minutes. The optical density of the supernatants at 540nm was measured after pelleting 
the cell debris by microcentrifugation, 
 
RNA interference 
293T cells were transfected in 6-well plates using a modified Lipofectamine 2000 
protocol. Cells were seeded at 3 × 105 cells per well in DMEM supplemented with 10% 
fetal bovine serum containing no antibiotics and transfected the following day with 
siGENOME siRNAs targeting Luciferase, Tsg101, Hrs, Alix, UBPY, or Eap45 
(Dharmacon). For single siRNA transfections, 40pmol siRNA was combined with 200ml 
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serum-free OptiMEM and a master mix consisting of 6µl Lipofectamine 2000 and 200µl 
OptiMEM per reaction was prepared. After incubating both mixtures at room temperature 
for 15 minutes, 206µl of the Lipofectamine 2000 mixture was added to each siRNA 
mixture and mixed gently by pipetting. After another 15-minute incubation at room 
temperature, the reactions were added to cells. Transfections were allowed to proceed for 
4 hours before replacing with fresh media. After 24 hours, cells were transfected again 
with the same siRNAs and the indicated Gag expression plasmids. VLP and cell lysates 
were prepared 48 hours after the second transfection. For combination knockdown 
experiments, 293T cells were transfected with 40 pmol of each siRNA, and the total 
amounts of siRNA tranfected were maintained at 80 pmol per reaction. To assess 
knockdown efficiency, 293T cells were transfected once with YFP-Tsg101, -Hrs, -ALIX, 
-UBPY, or -Eap45 expression plasmids and corresponding siRNAs. GFP expression in 













Chapter III. Direct viral protein ubiquitination is dispensable 
for ubiquitin ligase-dependent virus particle budding 
 
 The Gag proteins of several retroviruses carry low levels of ubiquitin 
[232,233,234], and the extent of ubiquitinaton appears to depend on the type of late 
domain they encode [112]. However, the functional relevance of direct Gag 
ubiquitination is disputed. On the one hand, mutation of multiple lysine residues in Gag 
blocks the late phase of HIV-1 and RSV budding at the plasma membrane without 
significantly affecting particle morphology [237,238]. On the other hand, budding 
efficiency does not necessarily correlate with the extent of Gag ubiquitination, as 
transplantation of PPxY late domains into late domain-deficient HIV-1 Gag leads to an 
increase in Gag ubiquitination but fails to rescue particle production [112]. Additionally, 
the inhibition of HIV-1 and RSV budding by extensive mutagenesis of Gag lysines may 
result from disruption of structural elements important for the late stage of particle 
release rather than the loss of ubiquitin acceptor sites. We noticed that the Gag proteins of 
the Spumaviruses (or Foamy viruses) are remarkably lysine-poor. This is an extremely 
unusual property, shared by all known members of the spumavirus subfamily (Table 4), 
to test whether ubiquitination of viral proteins is essential for the activity of late domains. 
 
Table 4. Abundance of basic residues in retroviral Gag proteins. 
 
Viral Gag HIV-1 MLV RSV MPMV PFV SFV-1 SFVcpz SFVora FeFV BFV EqFV 
Lys 38 31 30 58 1 0 2 1 8 0 1 
Arg 28 50 48 22 64 56 61 60 46 48 50 
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Spumaviruses comprise a unique subfamily of retroviruses (Fig. 9) with several 
distinguishing characteristics (reviewed in [242,243]). Prototype foamy virus (PFV) 
utilizes a dual promoter system for transcription. The internal promoter, which drives the 
expression of Tas and Bet accessory genes, exhibits higher basal activity than the LTR 
promoter. Tas encodes the viral transactivator protein, which enhances transcription from 
both the LTR and the internal promoter. Unlike orthoretroviruses, which express Pol as 
part of a Gag-Pol polyprotein, PFV expresses Pol from a separately spliced mRNA. The 
precise mechanism of Pol incorporation into virions is unclear but appears to require Pol 
interaction with Gag, either direct or through co-association of both proteins with the 
viral genomic RNA [244,245]. PFV Gag lacks the canonical Cys-His boxes required for 
RNA binding of orthoretroviral NC proteins. Instead, three glycine- and arginine-rich 
repeat regions (GR boxes) mediate Gag interaction with nucleic acids (both RNA and 
DNA) and nuclear import. Although the viral genome is packaged as RNA, reverse 
transcription occurs late in the viral lifecycle, before or during budding [246]. Therefore, 












Figure 9. Phylogenetic tree of 
retroviral pol sequences. The tree 
was derived by alignment of 
ungapped portions of Pol protein 
sequences. Taken from [243]. 
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The Gag protein of Foamy viruses does not undergo conventional processing into 
mature matrix (MA), capsid (CA), and nucleocapsid (NC) products. Instead the full-
length 72-kDa precursor is cleaved near its C-terminus into 68- and 4-kDa products, and 
the two high molecular weight proteins are detected in virions at approximately 
equimolar amounts [248]. PFV encodes PT/SAP as its primary L-domain (Fig. 10A), 
which induces viral particle release by binding to the Tsg101 component of ESCRT-I 
[240,249]. While PFV Gag only contains a single lysine (residue 396, Fig. 10A), there 
are potential ways in which the near-absence of lysine acceptors in FV Gag proteins 
could be circumvented while maintaining a requirement for viral protein ubiquitination in 
particle release. For example, unlike many retroviral Gag proteins, the N-terminus of 
PFV Gag is not myristoylated and could serve as a putative ubiquitin acceptor site. 
Additionally, FV Pol proteins do not exhibit the striking lysine-poor sequence bias of 
Gag and provide numerous opportunities for virion protein ubiquitination. Finally, FVs 
are unusual among retroviruses in that they pre-assemble complete capsids in the 
cytoplasm of infected cells and bud preferentially at intracytoplasmic membranes into 
vesicles, which are thought to be subsequently transported to the cell surface [250,251]. 
The leader peptide of the cognate Env protein is required to direct FV capsids to 
membranes for envelopment and release [248,252]. Notably, the cytoplasmic portion of 
the PFV Env leader peptide contains five lysine residues, which are extensively 
ubiquitinated [253]. Thus, virion proteins other than Gag could substitute for the 
presumed role of Gag ubiquitination in virion release. Therefore, we first derived an 
experimental system in which extracellular PFV VLPs were generated by Gag in the 






















Figure 10. Envelope-independent release of VLPs generated by membrane-targeted PFV 
Gag proteins. (A) Schematic representation of the PFV Gag protein, indicating relevant 
landmarks [the PSAP late domain, a single lysine residue, glycine/arginine (G-R)-rich 
domains, and a proteolytic cleavage site near the C-terminus of the ~72-kDa protein]. 
Also shown are the various membrane-targeting peptides that were appended to the PFV 
Gag N terminus. (B) Virion production by 293T cells transfected with the PFVΔEnv 
proviral plasmid, either alone or along with a PFV Env expression vector. Virion and cell 
lysates were analyzed by Western blotting with αPFV human serum. (C) VLP production 





Generation of PFV Gag virus-like particles in the absence of other virion proteins 
 Previous work, using the Src oncoprotein myristoylation signal, has shown that 
appending the amino terminus of PFV Gag with a membrane-targeting signal can bypass 
the requirement for Env coexpression in particle release [251]. However, like the Src 
signal, most peripheral membrane-targeting signals contain lysine residues, complicating 
the interpretation of experiments that test the functional role of Gag ubiquitin acceptors. 
Therefore, we designed PFV Gag proteins appended with candidate lysine-free plasma 
membrane-targeting peptides. These consisted of the following: (i) an artificial 
membrane targeting peptide (MyrR), comprising the minimal six-residue myristoylation 
signal of HIV-1 Gag followed by an arginine-rich linker; (ii) a ten-amino-acid 
myristylated and palmitoylated peptide derived from the N-terminus of the Fyn 
oncoprotein, in which two lysines were mutated to arginine (FynR); and (iii) a naturally 
lysine-free ten-amino-acid myristoylated and palmitoylated peptide from the N-terminus 
of the Lck oncoprotein (Fig. 10A). Control experiments confirmed that the authentic PFV 
Gag protein, expressed from a PFV proviral plasmid, was released in extracellular 
particles only when Env was coexpressed (Fig. 10B). Concordantly, expression of the 
PFV Gag protein in the absence of any other viral protein did not generate VLPs (Fig. 
10C). However, the membrane-targeted Gag proteins formed extracellular particles in the 
absence of Env expression. In the case of MyrR-Gag, VLP formation was inefficient, but 
the myristylated/palmitoylated Gag proteins (Fyn-Gag, FynR-Gag and Lck-Gag) 
efficiently generated extracellular VLPs (Fig. 10C). Since Lck-Gag formed VLPs with 
marginally greater efficiency than FynR-Gag, without introducing lysine residues, it was 
selected for further experiments. 
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Lck-Gag targets the plasma membrane and requires its PSAP motif to form 
extracellular VLPs 
 We next verified that our targeting strategy had the intended consequences. An 
Lck-Gag-CFP fusion protein efficiently targeted the plasma membrane in HeLa cells 
(Fig. 11A). Indeed, like most retroviral Gag-GFP fusion proteins, Lck-Gag-CFP was 
visible as fluorescent puncta at the cell surface, particularly when the cell surface-
coverslip interface was imaged. To confirm that Lck-Gag assembled into VLPs, it was 
expressed in HeLa and DF1 cells, which have unusually smooth surfaces, facilitating the 
detection of surface VLPs using scanning electron microscopy. Although we sometimes 
observed short filamentous particles on the surface of Lck-Gag-expressing HeLa or DF1 
cells, it was often difficult to observe retroviral VLPs by this technique, unless their 
release was arrested by coexpressing a dominant negative version of Vps4 [Vps4 
(E228Q)]. We observed numerous short filamentous particles extending from the surface 
of DF1 cells coexpressing Lck-Gag and Vps4 (E228Q) (Fig. 11B). While these differed 
from the spherical cytoplasmic particles that were assembled by non-membrane targeted 
PFV Gag, they were indistinguishable from those assembled by MLV Gag, which have 
been shown to be filamentous in the absence of co-expressed glycosylated Gag [254] or 
when L-domain function was inhibited [110,115]. 
 As additional verification of the authenticity of Lck-Gag assembly, we 
determined whether VLP release required an intact L-domain. Indeed, both the 
membrane targeting signal and the PSAP motif in Lck-Gag were required for VLP 
release (Fig. 11C). Thus, Lck-Gag mimics a conventional retroviral Gag protein in that it 
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assembles and is released at the cell surface via a plasma membrane-targeting signal and 















Figure 11. Lck-Gag forms VLPs at the plasma 
membrane that are released in a late domain-dependent 
manner. (A) HeLa cells expressing Lck-Gag-CFP 
(green) were fixed, and nuclei were stained with 
Hoechst (blue). Single deconvolved optical sections 
acquired at the center of the vertical dimension of the 
cell (Upper) or at the cell-coverslip interface (Lower) 
are shown. (B) Scanning electron micrograph of DF1 
cells transfected with Lck-Gag and GFP-VPS4(E228Q). 
Representative transfected (black arrow) and 
untransfected (white arrow) cells, identified by GFP 
expression, are shown (Left). A higher-magnification 
view of area indicated by the dashed box is also shown 
(Right). (C) VLP production by 293T cells expressing 
wild-type PFV Gag or Lck-Gag proteins encoding 
either wild-type or mutant (PSAP284–287 mutated to 





Class E VPS machinery- and ubiquitin ligase-dependent budding of lysine-free 
Gag 
 Next, we constructed Gag proteins devoid of ubiquitin acceptors by replacing the 
single lysine in Lck-Gag and Lck-Gag(PSAP-) with arginine (Fig. 12A). Because the 
amino terminus of Lck-Gag is occupied by myristoylation, this manipulation should 
remove all potential ubiquitin acceptor sites from Lck-Gag. Remarkably, the Lck-
Gag(K396R) protein efficiently generated extracellular VLPs (Fig. 12B), and this was 
dependent on engagement of the class E VPS machinery, because Lck-
Gag(K396R)(PSAP-) failed to generated extracellular VLPs (Fig. 12B). Notably, the 
efficiency with which Lck-Gag and Lck-Gag(K396R) formed VLPs was 
indistinguishable, strongly suggesting that viral protein ubiquitination is dispensable for 
the function of PT/SAP late domains. 
 Because P(T/S)AP-type late domains directly bind to Tsg101 to recruit the class E 
VPS machinery, they could conceivably bypass the requirement for ubiquitination and 
thereby supplant the perceived role of ubiquitin in viral budding. Therefore, we next 
determined whether Gag ubiquitination is required for the function of a late domain that 
acts via ubiquitin ligase recruitment. To this end, we appended a murine leukemia virus 
(MLV)-derived late domain to the C-terminus of Lck-Gag(K369R) in which the PSAP 
motif had been inactivated, generating Lck-Gag-PY (Fig. 12C). PPxY motifs recruit 
HECT ubiquitin ligases by binding their WW domains; therefore, to verify that the 
transplanted MLV-derived late domain could indeed recruit a ubiquitin ligase that can 
induce MLV budding (WWP1) [115], Lck-Gag-PY-CFP was coexpressed with YFP 









Figure 12. PT/SAP and PPxY-type late domains induce budding of lysine-free Gag 
proteins. (A) Schematic representation of lysine-free Lck-Gag proteins. (B) Western blot 
(αPFV) analysis of Lck-Gag expression in and VLP release from 293T cells transfected 
with Lck-Gag(K396R) expression plasmids encoding either the wild-type or mutant late 
domains. (C) Schematic representation of the Lck-Gag-PY protein, which is lysine free 
and encodes an MLV-derived late domain, appended at its C terminus. (D) YFP-WW 
fusion protein localization in HeLa cells coexpressing lysine-free Lck-Gag-CFP proteins 
encoding a PSAP motif, no late domain, or the MLV late domain, as indicated. (E) 
Western blot analysis (αPFV) of VLP production by 293T cells expressing lysine-free 
Lck-Gag proteins encoding the indicated late domains. (F) Western blot analysis (αPFV) 
(Top and Middle) of VLP production by 293T cells expressing Lck-Gag-PY. Cells were 
cotransfected with the indicated amounts of a YFP-VPS4(E228Q) plasmid, the 




































constitutively localizes to the nucleus but is relocalized, in a PPxY dependent manner,  
when coexpressed with MLV Gag or Ebola virus matrix [115]. Notably, YFP-WW was 
efficiently recruited to the plasma membrane in cells coexpressing Lck-Gag-PY-CFP, but 
remained in the nucleus of cells expressing Lck-Gag proteins lacking the MLV late 
domain (Fig. 12D). Thus, the MLV PPxY motif was capable of recruiting WWP1 in the 
context of Lck-Gag-PY. 
 Remarkably, The PPxY late domain stimulated the budding of lysine-free Lck-
Gag (Fig. 12E), albeit less efficiently than the natural PSAP late domain (Fig. 12E). 
Moreover, Lck-Gag-PY particle release was inhibited by Vps4 (E228Q) overexpression, 
indicating that the requirement for a functional class E VPS pathway in PPxY-dependent 
budding of PFV Gag was maintained (Fig. 12F). Thus, a late domain that functions by 
recruiting ubiquitin ligases appeared fully capable of inducing the release of VLPs using 
the Class E VPS machinery, despite the absence of ubiquitin acceptor sites in the viral 
protein. 
 
A catalytically active ubiquitin ligase (WWP1) can stimulate budding of a viral 
protein lacking ubiquitin acceptors 
 PPxY-dependent virus budding can sometimes be stimulated by overexpression of 
a HECT ubiquitin ligase. This effect is particularly evident with an attenuated MLV 
PPxY mutant exhibiting a partial budding defect that can be rescued by WWP1 
overexpression [115]. Notably, overexpression of YFP-WWP1 markedly enhanced the 
release of particles generated by Lck-Gag-PY (Fig. 13A). This effect required the PPxY 
motif in Lck-Gag-PY, because PSAP-dependent Lck-Gag VLP release was not enhanced 
 51 
(Fig. 13B), and release of an Lck-Gag lacking a functional late domain was not induced 
by WWP1 overexpression (Fig. 13C). Despite the fact that Lck-Gag-PY lacked ubiquitin 
acceptor sites, stimulation of VLP release required WWP1 catalytic activity. Indeed, 
expression of a truncated WWP1 lacking the catalytic domain (WWP1-ΔHECT) or an 
enzymatically inactive point mutant [WWP1(C890S)] inhibited rather than stimulated 
Lck-Gag-PY release (Fig. 13A). Again, these effects were specific to the PPxY  late 
domain, as PSAP-dependent and late domain-independent Lck-Gag VLP release was not 
affected (Fig. 13B). Thus, Lck-Gag-PY can recruit WWP1, but the effect of this 
recruitment on particle budding was critically dependent on the catalytic activity of 











Figure 13. Ubiquitin-ligase-stimulated, PPxY-dependent budding of lysine-free Gag. 
Western blot (αPFV) analysis of Gag expression and VLP production by 293T cells 
expressing lysine-free Lck-Gag proteins: Lck-Gag-PY (A); Lck-Gag(K396R) (B); or 
Lck-Gag(PSAP-)(K396R) (C). Each Lck-Gag protein was coexpressed with unfused YFP 
as a control or YFP fused to WWP1, WWP1 lacking the HECT domain (WWP1-
ΔHECT), or a catalytically inactive mutant of WWP1 [WWP1(C890S)], as indicated. 
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Effects of addition of ubiquitin acceptor sites on Gag ubiqitination 
 To exclude the possibility that our PFV Gag proteins became ubiquitinated by an 
alternative mechanism, independent of lysine or amino terminal acceptors, we determined 
whether ubiquitinated Gag proteins were generated in our assays. As a positive control, 
we prepared an Lck-Gag expression plasmid containing late domain-proximal ubiquitin 
acceptors by appending three lysine residues to the C-terminus of Lck-Gag-PY 
(generating Lck-Gag-PY-3K, Fig. 14A). We immunoprecipitated Lck-Gag proteins from 
293T cell lysates, prepared twenty-four hours after co-transfection with plasmids 
expressing (i) Lck-Gag variants, (ii) HA-tagged ubiquitin, and (iii) wild-type or inactive 
mutant WWP1. Thereafter, ubiquitinated Lck-Gag species were detected by 
immunoblotting. Lck-Gag proteins were efficiently immunoprecipitated and detected 
using αPFV antibody (Fig. 14B), but ubiquitinated Lck-Gag was undetectable in cells 
expressing lysine-free proteins, regardless of which late domain was present, and even 
when WWP1 was overexpressed (Fig. 14B). However, immunoprecipitates from cells 
expressing Lck-Gag-PY-3K contained several HA-reactive species corresponding to 
mono and oligoubiquitinated Gag (Fig. 15B upper panel). A secondary band of slightly 
higher molecular weight than Lck-Gag-PY-3K, likely corresponding to a 
monoubiquitinated species, was also detected using αPFV in cells expressing Lck-Gag-
PY-3K, but not Lck-Gag-PY (Fig. 15B, center and lower panels). These ubiquitinated 
forms reflect HECT ligase-mediated ubiquitination, as they were observed only in cells 
overexpressing catalytically active, but not catalytically inactive, WWP1. Thus, despite 




















Figure 14. Lysine-dependent, WWP1-induced ubiquitination of Lck-Gag. (A) Schematic 
representation of the Lck-Gag protein appended with the MLV late domain and three 
lysine residues at its C terminus (Lck-Gag-PY-3K). (B) Western blot 
(WB)/immunoprecipitation (IP) analysis of Lck-Gag proteins encoding the indicated late 
domains from 293T cells cotransfected with plasmids expressing Lck-Gag proteins, HA-
ubiquitin, and unfused YFP, YFP-WWP1, or YFP-WWP1(C890S). All Lck-Gag proteins 
were lysine free except Lck-Gag-PY-3K. (Top and Middle) The αPFV 
immunoprecipitates were analyzed by Western blotting with an αHA monoclonal 
antibody (Top) or αPFV serum (Middle). (Bottom) Alternatively, unfractionated cell 
lysates were probed with αPFV serum. For the αHA blot, the migration of molecular 
weight markers is indicated to facilitate assignment of ubiquitinated forms. 
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only as a consequence of insertion of lysine residues at the C-terminus. Therefore, lysine-
free Lck-Gag proteins appear to be resistant to ubiquitination by WWP1. 
 
Lck-Gag ubiquitination does not enhance particle release 
 We next determined whether the presence of ubiquitin acceptors, and ubiquitin 
conjugation, could enhance PPxY-dependent particle release. First, we compared Lck-
Gag-PY with Lck-Gag-PY-3K, whose release is dependent on HECT ubiquitin ligases 
and differ only in the presence or absence of late domain-proximal ubiquitin acceptors. 
Notably, Lck-Gag-PY-3K generated extracellular VLPs with no greater efficiency than 
lysine-free Lck-Gag-PY (Fig. 15A, left panel). Moreover, ubiquitinated Gag species were 
detectable in VLPs assembled by Lck-Gag-PY-3K, but not lysine free Gag proteins (Fig. 
15A, right panel). Thus, under conditions where ubiquitinated Gag is, or is not, 
generated, VLP release was equivalent. Additionally, WWP1 stimulated the release of 
particles generated by using Lck-Gag-PY-3K (Fig. 15B, C). Importantly, the magnitude 
of this effect was no greater than that observed with lysine-free Lck-Gag (Fig. 15B). 
Thus, WWP1-stimulated, PPxY-dependent particle release occurred equivalently whether 
or not it was accompanied by Gag ubiquitination. 
 
Summary 
 We generated a plasma membrane-targeted lysine-free PFV Gag protein (Lck-
PFV Gag) that can assemble at the cell surface and form extracellular virus-like particles 


















Figure 15. Presence of ubiquitin acceptors or Gag ubiquitination does not affect 
ubiquitin-ligase-induced Lck-Gag budding. (A) Western blot analysis of VLP production 
by 293T cells coexpressing HA-ubiquitin and the indicated PFV Gag proteins. VLP 
lysates were analyzed by Western blotting with αPFV serum (Left) or monoclonal αHA 
antibody (Right). Migration of molecular weight markers is indicated to facilitate 
assignment of ubiquitinated forms. (B) Western blot (αPFV) analysis of VLP production 
by Lck-Gag-PY proteins that were lysine-free or that bore three appended lysine residues 
at the C- terminus, as indicated. The Lck-Gag-PY proteins were expressed either with 





dispensable for both PSAP- and PPxY-dependent budding of Lck-PFV Gag. Moreover, 
overexpression of HECT ubiquitin ligase WWP1 specifically stimulated PPxY-dependent 
particle production by lysine-free Lck-Gag. Importantly, the catalytic activity of WWP1 
was required to promote PPxY-dependent budding in the presence and absence of 
ubiquitin acceptor sites within Gag. Taken together, our findings suggest that HECT 
ligases mediate late domain dependent budding by ubiquitinating transacting cellular 

































Chapter IV. Comparative analysis of HECT domain function  
 
 The Class E VPS pathway must be intact to support HECT ubiquitin ligase-
dependent virion release. The yeast HECT ligase Rsp5 is dispensable for MVB 
biogenesis but required for sorting of some endosomal cargoes [225]. In essence, PPxY 
late domains allow viral Gag proteins to be recognized by the Class E pathway as a 
specific type of cargo by recruiting HECT ligases, but the biochemical link between the 
ligases and the VPS machinery remains elusive. 
 A wild-type catalytic domain is essential for HECT ligase-mediated enhancement 
of PPxY-dependent budding [115,255], but the precise mechanism of this stimulation is 
unclear. Expression of enzymatically inactive WWP1, containing a single point mutation 
that disrupts its active site (C890S), fails to stimulate PPxY-dependent budding ([115] 
and Fig. 14B). Moreover, expression of truncated WWP1, lacking the entire catalytic 
domain, induces a more potent dominant negative effect on MLV budding than 
overexpression of the catalytic point mutant [115], suggesting that the HECT domain 
may encode additional elements that contribute to its ability to engage the Class E VPS 
machinery. Indeed, WWP1 localizes to aberrant endosomal compartments induced by 
overexpression of dominant negative Vps4, and this recruitment is largely dependent on 
its HECT domain [115]. Thus, HECT domains may mediate the interaction of full-length 
ubiquitin ligases with VPS factors, which are trapped on these aberrant compartments. 
Such interactions have not been convincingly documented by protein-protein binding 
assays and may be indirect, requiring unidentified bridging factors. 
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 Nine members of the Nedd4-like HECT ubiquitin ligase family have been 
described in humans, with regulatory roles in cell signaling, endocytosis, protein 
trafficking, and viral budding (reviewed in [209]). These ubiquitin ligases vary in their 
ability to promote PPxY-dependent MLV virion release, due at least in part to differences 
in the abilities of their WW domains to bind the MLV late domain [115]. A comparative 
analysis of HECT domain activities, including substrate ubiquitination and budding 
stimulation, could provide useful clues about their mechanistic role in VPS pathway 
engagement. 
 
Catalytically active HECT domains stimulate PPxY-dependent budding with 
variable efficiency  
 To distinguish the features of HECT domains that are important for stimulation of 
virus particle release we compared the various activities of isolated HECT domains. 
Since WWP1 has been previously shown to strongly interact with the MLV late domain 
[115], we constructed a series of chimeric ubiquitin ligases, consisting of the membrane 
targeting and PPxY motif-binding domains (C2-WW) of human WWP1 and different 
catalytic domains, derived from human WWP2, Nedd4, Nedd4L, Itch, Smurf1, or Bul2 or 
yeast Rsp5 HECT ligases (Fig. 16A). Overexpression of chimeric HECT ligases 
markedly reduced the expression of MLV GagPol in cell lysates (data not shown), 
perhaps by inducing its degradation, making it difficult to compare their effects on 
budding. Thus, we used a Gag protein containing minimal ubiquitin acceptor lysine 
residues. Lysine-free Prototype foamy virus (PFV) Gag (Lck-PFV Gag) can assemble at 












Figure 16. Stimulation of PPxY-dependent VLP production by chimeric HECT ligases. 
(A) Schematic representation of YFP-fused chimeric ubiquitin ligases containing the 
membrane targeting (C2) and late domain binding (WW) domains of WWP1 and the 
indicated catalytic HECT domains. Wild-type and catalytically inactive mutant (C-S) 
versions of each HECT ligase were constructed. (B) Quantitative Western blot (LICOR) 
analysis of VLP release from 293T cells coexpressing Lck-Gag-PY and the indicated 












































































































































































its naturally encoded PSAP late domain or a heterologous PPxY late domain, derived 
from MLV Gag. Expression of ubiquitin ligases containing any wild-type HECT domain, 
except that of human WWP2 and yeast Rsp5, stimulated PPxY-dependent budding of 
lysine-free Lck-PFV Gag (Fig. 16B). The strongest stimulation was observed with 
Nedd4L and Itch HECT domains. In contrast, overexpression of all enzymatically 
inactive chimeric ligases, in which the catalytic cysteine was mutated to serine, inhibited 
PPxY-dependent VLP production, suggesting that the catalytic activity of HECT domains 
is indispensable for stimulation of virion release. 
 
Stimulation of PSAP-dependent VLP release by recruitment of catalytically active 
HECT domains 
 The VPS factor Tsg101 functions essentially as an adaptor protein, which recruits 
ESCRT-I proteins to Gag. The N-terminal ubiquitin E2 variant (UEV) domain of Tsg101 
interacts with ubiquitin and P(T/S)AP peptide motifs [103,147,148,256], whereas the C-
terminal portion of the protein interacts with ESCRT-I components Vps28 and Vps37 
[149,241,257]. To determine whether P(T/S)AP-dependent VLP production can be 
redirected through the ubiquitin ligase-dependent pathway, we constructed chimeric 
proteins containing the UEV domain (residues 1-157) of Tsg101 fused to one of several 
human HECT domains (Fig. 17A). To assess the enhancement of PSAP-dependent 
budding, we constructed an attenuated “leaky” budding mutant of Lck-PFV Gag by 
changing the first proline residue of the PSAP motif to alanine. Expression of chimeric 
Tsg-HECT proteins containing wild-type WWP1 and Nedd4L HECT domains induced 
partial rescue of Lck-Gag-ASAP budding, while expression of a chimeric protein 
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containing the Itch catalytic domain completely rescued particle production. 
Overexpression of catalytically inactive chimeric Tsg-HECT proteins inhibited Lck-PFV 
Gag-ASAP VLP release (Fig. 17B). Thus, ubiquitin ligase activity at sites of VLP 
assembly appears to stimulate particle production, irrespective of its mode of recruitment 































Figure 17. Stimulation of PSAP-dependent budding by catalytically active HECT 
domains. (A) Schematic representation of a chimeric ubiquitin ligase containing the UEV 
domain of Tsg101 (PSAP binding) and the catalytic domain of a HECT ligase. (B) VLP 
production from 293T cells expressing Lck-PFV Gag containing either a wild-type 
(PSAP), inactive (ΔPSAP), or attenuated (ASAP) late domain and the indicated chimeric 
ubiquitin ligase. 
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Stimulation of PFV Gag budding correlates with HECT ligase auto-ubiquitination 
rather than Gag ubiquitination 
 To assess the relative catalytic activities of HECT domains, we compared the 
abilities of chimeric HECT ligases to ubiquitinate themselves and a PFV Gag substrate, 
encoding three lysine residues in close proximity to a PPxY late domain (Lck-Gag-PY-
3K). We immunoprecipitated PFV Gag and HECT ligases from 293T cell lysates, 
prepared 36 hours after co-transfection with plasmids expressing Lck-Gag-PY-3K, HA-
tagged ubiquitin, and YFP-fused chimeric HECT ligases encoding wild-type catalytic 
domains. Cell lysates were prepared using detergent-rich buffer (0.5% SDS) to ensure 
complete dissolution of protein complexes, and ubiquitinated species were detected by 
immunoblotting with an αHA antibody. 
 All of the tested chimeric ligases induced PPxY-dependent PFV Gag 
ubiquitination (Fig. 18A), but no correlation between direct Gag ubiquitination and 
stimulation of VLP production was apparent. Bul2 and Nedd4 HECT domains, which 
induced the highest and lowest levels of Gag ubiquitination, respectively, stimulated 
budding to a similar extent (about 6-fold). Moreover, the Rsp5 HECT domain, which 
induced high levels of Gag ubiquitination, enhanced budding only marginally. 
 In contrast, we observed a broad, albeit imperfect correlation between the ability 
of HECT ligases to self-ubiquitinate and to stimulate VLP production (Fig. 18B). Ligases 
that strongly promoted particle release (Itch and Nedd4L HECT domains) carried more 
ubiquitin, while those that failed to promote VLP release (WWP2 and Rsp5 HECT 
domains) carried relatively little. The correlation was imperfect, however, since Nedd4, 























Figure 18. Chimeric HECT ligases induce different levels of Gag- and auto-
ubiquitination. Quantitative Western blot analysis of lysine-containing PFV Gag proteins 
(A) and chimeric HECT ligase proteins (B), immunoprecipitated from 293T cells co-
transfected with plasmids expressing Lck-Gag-PY-3K, HA-ubiquitin, and the indicated 
chimeric YFP-HECT ligases. The αPFV immunoprecipitates were probed with an αHA 
monoclonal antibody (A, top) or αPFV serum (A, middle). The αGFP 
immunoprecipitates were probed with αHA (B, top) and αGFP (B, middle) monoclonal 
antibodies. Alternatively, unfractionated cell lysates were probed with αPFV serum or 
αGFP antibody (A and B, bottom). 
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Notably, all HECT domains localized to Vps4-induced Class E compartments, but there 
was no apparent correlation between their recruitment to class E compartments and 
ability to stimulate budding (Fig. 19). 
 Our data support our previous finding that direct Gag ubiquitination is 
dispensable for HECT ligase-dependent budding [255] and suggest a hypothesis that the 
total amount of ubiquitin deposited at sites of virion assembly is important for stimulation 
of particle release, rather that the identity of the protein to which it is ligated. HECT 
ligase auto-ubiquitination might account for the majority of total ubiquitin present in the 
vicinity of PPxY-dependent Gag assembly. However, we have been unable to directly 
assess the total levels of protein ubiquitination induced by each chimeric ligase when it is 
in a complex with Gag, due to the inefficient solubility of the ubiquitinated complexes 
under conditions that preserve protein-protein interactions. Thus, we cannot rule out the 
possibility that HECT domains recruit VPS proteins, either directly or through bridging 
factors, since auto-ubiquitination of HECT ligases may enhance their affinity for 
downstream binding partners that, in turn, could allow Class E pathway engagement.  
 
Stimulation of PPxY-dependent budding by direct recruitment of ESCRT-I 
 To determine whether the requirement for enzymatically active ubiquitin ligase 
recruitment for PPxY-dependent budding could be bypassed, we constructed chimeric 
proteins by replacing the HECT domain of WWP1 with the C-terminal portion of Tsg101 
(TsgΔUEV, residues 157-390, Fig. 20A). Overexpression of WWP1-TsgΔUEV 
stimulated Lck-PFV Gag-PY budding in a dose-dependent manner but had no effect on 
























Figure 19. HECT domain recruitment to dominant negative Vps4-induced Class E 
compartments. Subcellular localization of indicated YFP-HECT domains in 293T cells 
coexpressing CherryFP-Vps4(E228Q). 
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Thus, the chimeric protein seems capable of recruiting a functional ESCRT-I complex to 
assembling virions that encode PPxY late domains, thereby stimulating VLP production. 
Interestingly, WWP1-TsgΔUEV overexpression inhibited PSAP-dependent Lck-PFV 
Gag budding in a dose-dependent manner (Fig. 11B, right panel). Presumably, since the 
chimeric protein lacks the structural elements required for interaction with PSAP motifs, 
it can act as a dominant negative inhibitor of PSAP-dependent budding by sequestering 









Figure 20. Stimulation of PPxY-dependent budding by direct recruitment of ESCRT-I. 
(A) Schematic representation of a chimeric protein designed to recruit ESCRT-I to PPxY 
late domains, containing the C2 and WW domains of WWP1 fused to a Tsg101 fragment 
lacking the UEV domain (TsgΔUEV). (B) VLP production from 293T cells expressing 





 Humans encode several Nedd4-like ubiquitin ligases, which vary in their ability to 
stimulate PPxY-dependent MLV budding. HECT ligases may promote budding either by 
recruiting cellular factors to sites of virus particle assembly or by depositing ubiquitin 
onto proteins in the vicinity. To distinguish between these two alternatives we compared 
the capacity of different catalytic HECT domains to stimulate PFV budding and 
ubiquitination. We generated chimeric ubiquitin ligases that interact with either PPxY or 
PT/SAP-type late domains and contain different HECT domains. The ability of these 
ligases to stimulate PFV particle production was absolutely dependent on their catalytic 
activity, irrespective of their mode of recruitment to Gag. Moreover, the efficiency with 
which they stimulated budding  correlated with the extent of their auto-ubiquitination. 
Interestingly, PPxY dependent budding could be enhanced in the absence of ubiquitin 















Chapter V. Direct ubiquitin fusion to Gag replaces late   
domain function 
 
 Stimulation of PPxY-dependent viral budding is strictly dependent on the 
catalytic activity of HECT ubiquitin ligases. However, the strength of the stimulation 
correlates, broadly, with the extent of HECT ligase autoubiquitination rather than Gag 
ubiquitination. This is consistent with several possible models for HECT ligase-mediated 
budding. HECT domains may contain structural elements that are normally inaccessible 
but can be activated to engage the Class E VPS pathway by conformational changes, 
induced by ubiquitination. Alternatively, HECT domains may contain suboptimal binding 
sites, whose affinity for class E factors or bridging factors is enhanced by ubiquitination. 
Finally, ubiquitin itself could serve as a docking site for Class E factors, many of which 
contain ubiquitin interacting motifs, and the actual identity of the substrate for 
ubiquitination may be unimportant, provided that it is proximal to the site of particle 
budding. In this case, HECT ligase autoubiquitination could simply represent the 
majority of ubiquitin present at viral assembly sites, since ubiquitin acceptor lysine 
residues are much more abundant in the ligases than in PFV Gag. 
 If the substrate for HECT ligase-mediated ubiquitination is indeed irrelevant, and 
PPxY late domains merely serve to concentrate ubiquitinated protein species in the 
vicinity of virus particle assembly, direct fusion of ubiquitin to Gag may obviate the need 
for a conventional late domain. Two previous studies have described late domain-like 
activity of ubiquitin that has been appended directly to Gag. Ubiquitin fusion to the C-
terminus of RSV Gag rescues virus-like particle production in cells treated with 
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proteasome inhibitors but fails to compensate for the deletion of the PPxY late domain 
[104]. Fusion of ubiquitin to EIAV Gag promotes VLP release by late domain-deficient 
Gag but does not enhance budding of Gag encoding functional late domains [258]. 
Moreover, ubiquitin-dependent budding of EIAV Gag requires an intact Class E VPS 
pathway and a key hydrophobic surface patch of ubiquitin that mediates its recognition 
by ubiquitin-binding proteins. Lysine free PFV Gag, which cannot otherwise be modified 
by ubiquitin, offers a unique context for testing the effect of Gag-ubiquitin fusion on VLP 
production. 
  
Direct fusion of ubiquitin to PFV Gag promotes VLP release in the presence and 
absence of conventional late domains 
 To mimic the deposition of ubiquitin at sites of virion assembly without HECT 
domain recruitment we generated membrane targeted PFV Gag constructs with a single 
ubiquitin appended at the C-terminus. Ubiquitin is conjugated to proteins by an 
isopeptide bond between the C-terminal glycine residue of ubiquitin and the ε-amino 
group of a lysine residue within the substrate protein. Thus, to avoid aberrant linkage of 
our Gag-ubiquitin chimeras to other proteins we deleted two glycine residues from the C-
terminus of ubiquitin (Fig. 21A). 
 Remarkably, cells expressing ubiquitin-fused late domain-deficient Lck-PFV Gag 
(ΔPSAP-Ub) efficiently produced VLPs, whereas those expressing its unfused 
counterpart (ΔPSAP) produced undetectable levels (Fig. 21B, left panel). Moreover, 
attachment of ubiquitin to the C-terminus of PFV Gag containing a wild-type late domain 
(PSAP-Ub) greatly enhanced its particle production (Fig. 21B, right panel). To determine 
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the amount of ubiquitin necessary to promote PFV budding we titrated ubiquitin-fused 
Gag in a VLP production assay while keeping total levels of Gag constant. In the absence 
of conventional late domains, almost all of the Gag proteins must carry ubiquitin to 
support efficient VLP release (Fig. 21D, left panel). However, in the presence of a PSAP 
late domain, potent stimulation of VLP release was observed when only 25% of Gag 
carried ubiquitin (Fig. 21D, right panel). Thus, ubiquitinated species be present at sites of 
VLP assembly stimulate budding, in an apparently dose dependent manner. Moreover, 
ubiquitin appears to synergize with a late domain (i.e. a PTAP motif) to promote efficient 
VLP release. 
 Several enveloped viruses encode both PT/SAP and PPxY motifs within a single 
structural protein, with one typically playing a dominant role in promoting particle 
release. The activity of the secondary late domain usually becomes apparent only when 
the primary late domain is inactivated [193,259,260,261]. In the case of lysine-free Lck-
PFV Gag, PSAP- and PPxY-dependent budding is relatively inefficient. However, when 
both late domains are present together within the same Gag protein, their activities appear 
to synergize, resulting in potent stimulation of VLP release (Fig. 21C). Direct fusion of 
ubiquitin to the C-terminus of Gag presumably mimics the effect of efficient recruitment 
of a highly active ubiquitin ligase by a PPxY-type late domain. Hence, ubiquitin fusion to 
PFV Gag induces greater stimulation of VLP release than addition of a PPxY late 
domain. Moreover, particle production can be further enhanced by fusing ubiquitin to 














Figure 21. Direct fusion of ubiquitin to Lck-PFV Gag stimulates late domain-dependent 
and -independent budding. (A) Schematic representation of lysine-free Lck-PFV Gag 
with a single ubiquitin moiety fused at the carboxy terminus. Two glycine residues were 
removed from the C-terminus of ubiquitin to prevent its conjugation to other proteins.  
(B) VLP production from 293T cells expressing the indicated Lck-PFV Gag constructs. 
(C) Relative VLP release efficiency by 293T cells expressing Lck-PFV Gag containing 
the indicated late domains, alone or in combination with ubiquitin fusion, measured by 
quantitative western blot. (D) VLP production from 293T cells expressing Lck-Gag and 
Lck-Gag-Ub containing either the wild-type (PSAP) or inactive (ΔPSAP) late domain. 


































Ubiquitin-directed PFV budding is Class E pathway-dependent 
 Ubiquitin possesses several residues required for its polymerization and 
recognition by cellular signaling factors. Lys48 and Lys63 are involved in the formation 
of polyubiquitin chains, which target proteins for proteasomal degradation [262,263,264] 
or other regulatory events [264,265,266,267,268], respectively. Gln62 and Glu64 have 
been implicated in binding Tsg101 and its yeast homolog Vps23 [269]. Phe4 is important 
for ubiquitin-mediated receptor protein internalization [270,271]. Leu8 and Ile44 are key 
residues in a hydrophobic patch [271,272,273] that forms an essential interaction surface 
for numerous cellular proteins, including some VPS proteins (summarized in Table 5). 
Notably, overexpression of ubiquitin with mutated Phe4 and Ile44 residues has been 
shown to inhibit HIV-1 VLP production [273]. Mutagenic disruption of the Leu8/Ile44 
hydrophobic patch strongly inhibited ubiquitin-dependent rescue and enhancement of 
PFV Gag budding, whereas the other residues appeared to be dispensable (Fig. 22A). 
Thus, ubiquitin seems to mediate VLP production by recruiting cellular factors to sites of 
virion assembly, in effect serving as a late domain. 
 The function of all conventional retroviral late domains requires an intact Class E 
VPS pathway [103,108,122,123,124]. Thus, if budding of ubiquitin-fused Gag occurs by 
the same mechanism as that of PPxY-containing Gag, it should be inhibited by disruption 
of the Class E machinery. Indeed, budding of Lck-PFV-ΔPSAP-Ub and Lck-PFV-PSAP-
Ub was suppressed in a dose-dependent manner by overexpression of dominant negative 
Vps4 (E228Q) (Fig. 22B), indicating that ubiquitin can promote particle release only in 






















Figure 22. Ubiquitin-dependent VLP production requires Class E VPS machinery 
engagement. (A) VLP release from 293T cells expressing Lck-Gag-Ub containing either 
the wild-type or inactive late domain and the indicated mutations in ubiquitin. (B) VLP 
production from 293T cells expressing Lck-Gag-Ub containing either the wild-type or 
nonfunctional late domain and increasing amounts of GFP-Vps4 (E228Q). 
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Several Class E factors bind ubiquitin 
 Several Class E vacuolar protein sorting factors have been reported to encode 
ubiquitin interacting motifs (Table 5). Although the affinity of such domains for 
monoubiquitin is relatively weak (Kd >100µM), many Class E factors form multiprotein 
complexes that potentially contain several ubiquitin-binding surfaces, which could 
provide sufficient avidity for their interaction with ubiquitinated proteins. The efficiency 
with which ESCRT complexes are recruited to viral assembly sites would would likely be 
dependent on the concentration of ubiquitin in the vicinity of VLP assembly, which is 
consistent with our finding that a large fraction of Gag must carry ubiquitin to 
compensate for the absence of a late domain (Fig. 21D). We performed a yeast two-
hybrid assay to survey the binding of various Class E factors to ubiquitin containing 
either an intact (WT) or disrupted hydrophobic patch (I44A). Several factors exhibited 
binding interactions above background levels (Fig. 23); however, only HBP/STAM, 
CIN85, ALIX, and UBPY binding appeared to require the Ile44 hydrophobic patch. We 
note that multiple subunits of the ESCRT-I complex have been reported to bind ubiquitin 
or have domains that are predicted to bind ubiquitin [103,147,148,257,274], and while we 
were not able to detect interactions with individual subunits in out yeast two hybrid 







Table 5. Mammalian Class E factors encoding ubiquitin binding domains 
 
Class E factor Domain type Kd Methods References 
Tsg101 UEV ~500µM SPR, NMR, structure [103,147,148,274] 
Vps37A putative UEV  sequence [257] 
Hrs DUIM, VHS ~300µM, ~1.4mM IP, SPR, structure [161,274,275,276,277,
278,279] 
STAM UIM, VHS ~430µM, ~220µM IP, NMR [155,160,161,280] 
Eap45 GLUE ~300µM IP, SPR, structure [166,281,282] 
Eps15 UIM  IP, SPR [277,279] 
ALIX Unknown  IP [258] 
CIN85 SH3  IP, NMR [283] 







Figure 23. Several Class E vacuolar protein sorting factors interact with ubiquitin in a 
hydrophobic patch-dependent manner. Yeast two-hybrid analysis of the interaction 
between the indicated Class E factors and ubiquitin containing either an intact (Ub WT) 
or disrupted (Ub I44A) hydrophobic patch. β-galactosidase expression was measured as 
optical density at 540nm (OD540) in Y190 cells transformed with the indicated Gal4-
DNA binding domain (Gal4-BD) or activation domain (Gal4-AD) fusion constructs. 
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Perturbation of Class E factor function modestly affects ubiquitin-dependent 
budding 
 We sought to determine the sensitivity of ubiquitin-dependent rescue of PFV 
budding to perturbation of different branches of the Class E pathway. Therefore, we 
tested the efficiency of Lck-PFV Gag-ΔPSAP-Ub particle release in cells overexpressing 
either full length or putatively dominant negative fragments of several Class E factors 
with reported ubiquitin binding activity. Overexpression of the Tsg101 UEV domain, 
which binds ubiquitin but lacks the ability to recruit downstream components of the 
ESCRT pathway, inhibited ubiquitin-dependent budding of Lck-PFV Gag to a similar 
extent as P(T/S)AP-dependent budding of Lck-PFV Gag and HIV-1 Gag (about 3-fold, 
Fig. 24A). However, mutation of the ubiquitin-binding site of TsgUEV (N45A, 
[147,148]) had no effect on its ability to inhibit Lck-PFV budding (data not shown). 
Since the UEV domain interacts with PT/SAP motifs as well as ubiquitin, the N45A 
mutant UEV could, in theory, be recruited to Gag-ubiquitin assembly sites indirectly, by 
binding ESCRT-0 through the PSAP motif in Hrs. 
PSAP- and ubiquitin-dependent PFV Gag budding were both modestly inhibited 
by overexpression of Hrs, containing either a wild-type or mutated (LA265,266AL) 
ubiquitin binding pocket [159,277] (Fig. 24E and data not shown). Endogenous Hrs 
localizes to early endosomes, and its overexpression causes Tsg101 redistribution from 
late to early endosomes [158]. Moreover, overexpression of Hrs has been shown to 
inhibit HIV-1 budding by a mechanism that requires its interaction with Tsg101 [284]. 











Figure 24. Effect of Class E factor overexpression on ubiquitin-dependent budding of late 
domain-deficient PFV Gag. Quantitative Western blot analysis of relative VLP 
production by 293T cells expressing Lck-PFV Gag-ΔPSAP-Ub and increasing quantities 
of GFP-Tsg101UEV (A), YFP-ALIX (B), YFP-ALIX-ΔPRR (C), YFP-ALIX-ΔBro (D), 
YFP-Hrs (E), YFP-UBPY (F), or YFP-Eap45 (G). Effect of factor overexpression on 
VLP release from 293T cells expressing Lck-PFV Gag-PSAP (A, E, and G), HIV-1 Gag 






































its own ability to interact with ubiquitin, by sequestering endogenous Tsg101 away from 
sites of virus particle assembly. 
Expression of full length ALIX at concentrations that strongly stimulated budding 
of HIV-1 encoding a mutated PTAP motif [196] marginally enhanced ubiquitin-
dependent Lck-PFV Gag budding (Fig. 24B). Converesely, overexpression of ALIX 
fragments lacking either the Bro1 domain or the proline-rich region, which are important 
for interactions with CHMP4 and Tsg101, respectively [108,122,123,197,198], exhibited 
a strong dominant negative effect on YPDL-dependent EIAV budding and had no effect 
on Lck-PFV Gag-ΔPSAP-Ub budding (Fig. 24C, D).  
Overexpression of the wild-type and catalytically inactive deubiquitninating 
enzyme UBPY had no appreciable effect on ubiquitin-dependent VLP production (Fig. 
24F and data not shown). Overexpression of the ESCRT-II protein EAP45 slightly 
inhibited ubiquitin-dependent Lck-PFV Gag budding, and the inhibition was unaffected 
by mutations in the ubiquitin binding site of EAP45 (VFE67,68,70AAA [281,282]) (Fig. 
24G and data not shown). 
 
Inhibition of ubiquitin-dependent budding by Class E factor depletion 
 Overall, the effects of  ESCRT protein overexpression on ubiquitin dependent 
budding were rather modest and difficult to interpret. Therefore, We next determined the 
effect of siRNA depletion of ubiquitin-binding Class E factors on Lck-PFV Gag budding. 
Due to the inefficient knockdown of Hrs (Fig. 25E), its effect on budding could not be 
reliably assessed. We did not test the effect of STAM depletion, since it cannot associate 












Figure 25. Inhibition of Lck-PFV Gag budding by Class E factor depletion is late 
domain-specific. (A-D) Quantitative Western blot analysis of VLP production from 293T 
cells expressing Lck-PFV Gag-ΔPSAP-Ub (A), Lck-PFV Gag-PY (B), Lck-PFV Gag-
PSAP (C), or EIAV Gag (D) and siRNAs directed against the indicated Class E factors. 
(E) Quantitative Western blot analysis of siRNA Class E factor depletion. Lysates of 
293T cells transfected with GFP-Tsg101 or YFP-Hrs, -ALIX, -UBPY, or -Eap45 
expression plasmids and siRNAs targeting either luciferase (Control) or the specified 




































and thus appears to play an auxiliary role in ubiquitinated cargo recognition. 
Nevertheless, ubiquitin-dependent budding was modestly inhibited by depletion of 
Tsg101 or ALIX (2-3-fold) but not by depletion of UBPY or EAP45 (Fig. 25A). PPxY-
dependent budding of PFV Gag exhibited a similar pattern of inhibition by Class E factor 
knockdown but appeared to be more sensitive to Tsg101 depletion (Fig. 25B). In contrast, 
PSAP-dependent Lck-PFV Gag budding was specifically inhibited by depletion of 
Tsg101 (over 5-fold inhibition, Fig. 25C) and EIAV Gag budding was specifically 
inhibited by depletion of ALIX (about 4-fold inhibition, Fig. 25D). 
 Several Class E factors may serve redundant roles in recognizing ubiquitinated 
species and mediating ubiquitin-dependent virus particle release. Thus, we sought to 
determine whether simultaneous depletion of multiple factors, specifically Tsg101 and 
ALIX, would exhibit a stronger inhibitory effect on budding than depletion of individual 
factors. Class E factor knockdown was significantly less efficient under the conditions 
used for this assay (Fig. 26C), which may account for the lack of inhibition of VLP 
release by expression of siRNAs targeting ALIX. Nevertheless, cotransfection of Tsg101 
and ALIX siRNAs together had a significantly stronger inhibitory effect on both 
ubiquitin- and PPxY-dependent Lck-PFV Gag budding than expression of either siRNA 
alone (Fig. 26A, B). 
 
Summary 
 We generated ubiquitin-fused PFV Gag proteins to mimic ubiquitin deposition at 
viral assembly sites in the absence of HECT domain recruitment. Remarkably, direct 











Figure 26. Depletion of multiple Class E factors enhances VLP release inhibition. (A and 
B) Quantitative Western blot analysis of VLP production from 293T cells expressing 
Lck-PFV Gag-ΔPSAP-Ub (A) or Lck-PFV Gag-PY (B) and siRNAs targeting the 
indicated Class E factors. Cells transfected with a single Class E factor siRNA were co-
transfected with an equal amount of control siRNA to keep total siRNA levels constant. 
(C) Quantitative Western blot analysis of ectopically expressed fluorescent protein-fused 
Class E factor depletion in 293T cells transfected with multiple siRNAs. Cell lysates 




































absence of a conventioan L-domain, and potently stimulated PSAP-dependent budding. 
Ubiquitin-dependent particle production was abolished by overexpression of dominant 
negative Vps4 and diminished by mutations within the ubiquitin hydrophobic patch. 
Depletion of individual class E factors partially suppressed ubiquitin-dependent budding, 
and the effect was enhanced by simultaneous depletion of Tsg101 and ALIX, suggesting 




















Chapter VI. Discussion 
 
 Efficient separation of nascent virions from the plasma membrane requires 
engagement of the cellular Class E VPS pathway by late domains, short peptide motifs 
encoded within viral structural proteins. PT/SAP and YPxL/LxLF-type late domains 
recruit VPS factors with well-documented physical links to the ESCRT-III complex of 
the pathway, which is thought execute the membrane scission event critical for release of 
virons. On the other hand, PPxY late domains recruit Nedd4-like HECT ubiquitin ligases, 
which require their catalytic domains and an intact Class E pathway for their function in 
virus release. However, the mechanism of Class E machinery engagement by HECT 
ligases is poorly understood. Moreover, ubiquitin plays a general role in late domain-
dependent budding, as its depletion arrests the release of viruses that utilize different late 
domains at a late stage of budding, but its precise function is unclear. 
 The major structural proteins of several retroviruses become ubiquitinated as a 
consequence of late domain activity; however, it is unclear whether these modifications 
play a functional role in promoting virion release or if they are merely bystander 
reactions of promiscuous ubiquitin ligases. Two studies have shown that mutation of 
multiple lysine residues in HIV-1 and RSV Gag significantly inhibits particle production 
[237,238]. However, the budding defects observed in these studies may have been due to 
structural disruptions in Gag rather than the loss of ubiquitin acceptor sites. We took 
advantage of a naturally occurring lysine-poor Gag protein (PFV Gag) to generate a 
lysine free Gag that could direct the assembly of virus-like particles at the plasma 
membrane in the absence of other viral protein expression. Lysine free PFV Gag 
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supported efficient PSAP late domain-dependent particle release. Remarkably, direct 
ubiquitination of PFV Gag was dispensable for the function of the PPxY late domain, 
which nevertheless recruited HECT ligases and required their catalytic activity to 
promote budding. 
 Similar observations have been made with regard to vacuolar sorting of certain 
proteins in yeast. For example, recruitment of the yeast HECT ligase Rsp5 by Sna3, 
through a PPxY motif in its cytoplasmic tail, promotes Sna3 polyubiquitination and 
sorting into the MVB pathway. However, sorting of lysine free Sna3, which does not get 
ubiquitinated, still requires the catalytic activity of Rsp5 [225,226,227]. Thus, cargo 
protein ubiquitination is not universally required for ubiquitin ligase-dependent 
endosomal sorting using the VPS pathway. 
 In theory, HECT ligases could stimulate viral particle release via the Class E 
pathway by numerous mechanisms other than direct viral protein ubiquitination. The 
ligases themselves could function as scaffolds for VPS protein recruitment, either directly 
or through unidentified bridging factors. Our lab has previously shown that the isolated 
HECT domain of WWP1 can behave in soluble Class E factor-like manner, in that it is 
retained on aberrant endosomal compartments induced by overexpression of catalytically 
inactive Vps4 (E228Q) [115]. Moreover, physical interactions between Class E factors 
and HECT ligases have been reported, albeit not necessarily via the HECT domain. 
Specifically, Tsg101 can associate with a fragment of Nedd4 containing the C2 and WW 
domains [285], and Hrs can associate with and become ubiquitinated by Itch [286]. 
Alternatively, HECT ligase-mediated ubiquitination could modulate the stability, activity, 
or interactions of specific Class E factors or associated proteins. Indeed, several factors 
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involved in yeast and human endosomal trafficking can be ubiquitinated by HECT ligases 
[286,287]. Finally, since several Class E factors that function early in the pathway 
contain ubiquitin-binding domains, HECT ligase-mediated autoubiquitination, or 
ubiquitination of trans-acting factors, may serve to concentrate ubiquitinated species at 
virion production sites, thereby nucleating the assembly of the Class E machinery. 
 Since the catalytic domains of HECT ligases are critical for their late domain-
stimulating ability, we compared the activities of HECT domains from different members 
of the human Nedd4-like family of HECT ubiquitin ligases. We found the catalytic 
cysteine residue to be strictly required for stimulation of PPxY-dependent budding of 
lysine-free PFV Gag. Meanwhile, HECT ligase-mediated stimulation of VLP release did 
not correlate with HECT domain recruitment to mutant Vps4-induced Class E 
compartments. Thus, the ubiquitin conjugating activity of HECT domains appears to be 
critical for their role in particle release, even in the absence of direct Gag ubiquitination. 
This is consistent with recent findings that ISG15, a ubiquitin-like molecule, can inhibit 
PPxY-dependent release of vesicular stomatitis virus (VSV) and Ebola virus VP40 VLPs 
by suppressing the catalytic activity of Nedd4 and several related ubiquitin E3 ligases 
[228,229].  It is important to note that ISG15 inhibits Nedd4 autoubiquitination, and not 
merely viral protein ubiquitination, by blocking the association of Nedd4 with E2 
enzymes and impairing the formation of thioester-bound HECT-Ub intermediates [228]. 
 Catalytically active HECT domains varied in their ability to stimulate PPxY-
dependent particle release. Notably, chimeric HECT ligases exhibited similar patterns of 
stimulation of PPxY-dependent VLP production by lysine-free and lysine-containing 
PFV Gag (data not shown). We found this variability to correlate directly with the levels 
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of HECT ligase autoubiquitination, but not with their ability to ubiquitinate a Gag 
substrate that contains several lysines in close proximity to a PPxY motif. This is in 
agreement with our finding that direct Gag ubiquitination is dispensable for PPxY-
dependent budding and consistent with a model in which HECT ligases promote VLP 
release by ubiquitinating trans-acting factors. However, it is unclear whether 
ubiquitination of HECT ligases, specifically, is critical for Class E pathway engagement, 
or if autoubiquitinated ligases simply represent the one of the ubiquitinated protein 
species at virion assembly sites. 
 The C2 and WW domains appear to be dispensable for HECT ligase-mediated 
VLP release. Catalytically active HECT domains fused to the Tsg101 UEV domain 
stimulated PSAP-dependent budding, while the corresponding catalytically inactive 
mutants suppressed particle production. Thus, as long as they are enzymatically intact 
and can be recruited to sites of virion assembly, HECT domains encode all of the 
activities necessary for the promotion of VLP release. It seems unlikely, therefore, that 
HECT ligases engage the Class E pathway by recruiting substrates via their WW or C2 
domains. 
 The autoubiquitination activity of HECT E3 ligases has been linked to their 
ability to monoubiquitinate substrates by a mechanism called coupled ubiquitination 
[288]. Conventional HECT ligase substrate recognition occurs via relatively stable 
interactions between the WW domains of the ligase and the PPxY motifs in the substrate. 
In contrast, proteins that contain ubiquitin interacting motifs (UIMs), sometimes referred 
to as “ubiquitin receptors”, can transiently associate with autoubiquitinated HECT ligases 
and become monoubiquitinated in the absence of WW-PPxY interactions. Thus, it is 
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conceivable for autoubiquitinated HECT ligases to promote VLP release by recruiting 
UIM-containing VPS proteins to sites of virion assembly. Interestingly, the catalytically 
active WWP2 HECT ligase, which does not exhibit a significant amount of 
autoubiquitination, cannot ubiquitinate UIM-containing substrates, presumably because it 
cannot efficiently recruit them [288]. Similarly, the weak autoubiquitination of our 
chimeric WWP1/WWP2 HECT ligase could account for its inability to engage the Class 
E machinery and thereby stimulate PPxY dependent PFV Gag budding in our 
experimental system. 
 Remarkably, direct fusion of a single ubiquitin moiety to the C-terminus of PFV 
Gag potently stimulated late domain-dependent and -independent budding. Direct 
ubiquitin fusion to RSV Gag has previously been shown to rescue the late budding defect 
in cells treated with proteasome inhibitors [104]. However, ubiquitin fusion cannot 
compensate for the deletion of the RSV late domain or further stimulate wild-type RSV 
Gag budding. Additionally, ubiquitin fusion rescues budding of EIAV Gag with an 
inactive late domain but has no effect on late domain-dependent EIAV Gag budding 
[258]. To our knowledge, our study is the first to demonstrate strong enhancement of late 
domain-dependent VLP production by direct fusion of ubiquitin to Gag. This could be 
attributed to inherently inefficient cofactor recruitment by the natural PFV late domain. 
Ubiquitin may serve as an additional docking site for VPS factors, thereby synergizing 
with the late domain to optimally utilize the available cellular Class E machinery. 
 Although we have not visually ascertained that the PFV Gag-ubiquitin fusion 
protein can assemble into bona fide VLPs, ubiquitin-dependent particle release occurred 
by a regulated mechanism. The Ile44 hydrophobic patch of ubiquitin, which is an 
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important interaction surface for various ubiquitin-binding domains (e.g. UIM, UBD, 
GLUE, etc.), was essential for the rescue of late domain-deficient Gag budding. 
Additionally, ablation of Class E machinery function by overexpression of catalytically 
inactive Vps4 suppressed ubiquitin-dependent particle production. Moreover, particles 
formed by ubiquitin-fused EIAV Gag are morphologically similar to those assembled by 
wild-type EIAV Gag [258]. 
 Since ubiquitin-binding domains have a very low affinity for individual ubiquitin 
molecules and thus primarily mediate transient interactions, efficient retention of UIM-
encoding Class E factors in the vicinity of Gag assembly sites would require an 
abundance of UIM docking sites. Indeed, the five ubiquitin binding domains (two VHSs 
and three UIMs) of ESCRT-0 have been shown to cooperatively bind polyubiquitin, but 
not mono- or diubiquitin, with high avidity, requiring at least three functional ubiquitin 
binding sites to support detectable levels of cargo sorting [161]. In agreement with this 
model, direct ubiquitin fusion to PFV Gag could effectively bypass the need for late 
domain-dependent recruitment of Class E factors only when a large fraction (~50%) of 
Gag molecules carried ubiquitin. This equates to about 1000 or more ubiquitin monomers 
per virion, assuming that ubiquitin-fused and unfused Gag molecules are incorporated 
into assembling particles with equivalent efficiency.  
 As with conventional late domain-dependent particle production, the Class E VPS 
pathway must be intact to support ubiquitin-dependent budding. Ablation of individual 
segments of the pathway resulted in partial inhibition of ubiquitin- and PPxY-dependent 
particle release. However, simultaneous depletion of Tsg101 and ALIX caused a stronger 
suppression of particle release than depletion of either factor alone, suggesting that they 
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may serve redundant roles in ubiquitin-dependent budding. Multiple ubiquitin-interacting 
domains within ESCRT-0, ESCRT-I, ESCRT-II and associated factors could, in 
principle, provide parallel mechanisms for ubiquitin-dependent engagement of the VPS 
machinery. Indeed, this was recently demonstrated in yeast, where simultaneous 
disruption of ubiquitin binding by ESCRT-I, ESCRT-II and Bro1 (ALIX homolog) and 
the association between ESCRT-I and ESCRT-0 was necessary to completely block the 
sorting of ubiquitinated cargo to the lysosome [154]. This suggests that all entry points 
into the Class E pathway must be simultaneously ablated to completely inhibit ubiquitin- 
or HECT ligase-dependent budding. 
 
Future directions 
 Although we have not performed a detailed analysis of the specific types of 
ubiquitin modifications generated by our chimeric HECT ligases, we noticed variability 
in the distribution of synthesized chain lengths. For instance, WWP1/Itch preferentially 
formed longer polyubiquitin chains, whereas WWP1/Bul2 and WWP1/Rsp5 formed 
relatively high proportions of mono- or diubiquitinated products. These differences could 
contribute to the relative efficiency with which HECT ligases stimulate virus particle 
production. Moreover, the ubiquitin chains synthesized by various ligases may differ in 
the types of lysine linkages they contain. Full-length Rsp5, Nedd4, and Itch ligases have 
been shown to form Lys63-linked chains more efficiently than other types of 
polyubiquitin chains [289], but the linkage specificity of other Nedd4 family members 
has not been reported. The multivalent ESCRT-0 complex binds Lys63-linked ubiquitin 
chains with greater affinity than Lys48-linked or linear head-to-tail ubiquitin chains 
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[161]. Thus, chain length and linkage specificity could influence the ability of ubiquitin 
ligases to engage the Class E machinery. 
 Several aspects of HECT domain biochemistry are amenable to experimental 
manipulation. We can force certain types of ubiquitin chain linkages to be 
overrepresented or excluded in ubiquitin transfer or VLP production assays by 
overexpression of ubiquitin mutants that either contain or lack specific lysine residues. 
Thus, we could assess the chain type specificity of our chimeric HECT ligases and 
determine whether certain ubiquitin linkage types are preferentially recognized by the 
VPS machinery to promote virus particle release. The specificity for Lys48 or Lys63-type 
linkages is thought to be determined by a 60-residue segment at the HECT domain C-
terminus [289]. We could thus, in principle, assess the relative importance of ubiquitin 
linkages in viral budding by swapping this domain between HECT ligases with different 
linkage specificities. Since all of the Nedd4-like HECT domains tested thus far 
preferentially generate Lys63-linked ubiquitin chains, it would be interesting to test the 
ability of the E6AP HECT domain, which preferentially forms Lys48-linked chains 
[289], to stimulate PPxY-dependent VLP release. 
 HECT domains possess additional mechanisms that regulate their enzymatic 
activity. For example, the highly conserved α1 helix suppresses the overall catalytic 
activity of HECT domains and preferentially inhibits their autoubiquitination [290]. 
Disruption of interactions between the α1 helix and the HECT domain N-lobe may 
increase HECT ligase promiscuity and have interesting implications for their ability to 
promote VLP release. Additionally, the N-lobe of HECT domains contains a noncovalent 
ubiquitin binding site, which enables polyubiquitination by some HECT ligases and 
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limits the length of ubiquitin chains produced by others [213,214]. Thus, it would be 
interesting to test the effect of ubiquitin binding site disruption on the ubiquitination and 
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